
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">

<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta http-equiv="x-ua-compatible" content="ie=edge">
<meta http-equiv="cache-control" content="no-cache" />
<meta http-equiv="Pragma" content="no-cache" />
<meta http-equiv="Expires" content="-1" />
<meta name="robots" content="all" />
<link rel="shortcut icon" href="https://www.omicsonline.org/images/animated_favicon.gif" />

<link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.1.1/css/bootstrap.min.css">
<link rel="stylesheet" href="https://www.omicsonline.org/css/jquery.mCustomScrollbar.css" />
<link rel="stylesheet" href="https://www.omicsonline.org/css/global.css">
<link rel="stylesheet" href="https://www.omicsonline.org/css/styles.css">
<link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i&amp;subset=cyrillic,cyrillic-ext,greek,greek-ext,latin-ext,vietnamese" rel="stylesheet">
<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.0.9/css/all.css">
<link rel="stylesheet" type="text/css" href="https://www.omicsonline.org/css/main-coolautosuggest.css" />
<script src="https://code.jquery.com/jquery-3.3.1.min.js" type="b97a614b378fa63bf320b38b-"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.3/umd/popper.min.js" type="b97a614b378fa63bf320b38b-"></script>
<script src="https://stackpath.bootstrapcdn.com/bootstrap/4.1.1/js/bootstrap.min.js" type="b97a614b378fa63bf320b38b-"></script>
<script src="https://www.omicsonline.org/js/jquery.coolautosuggest.js" type="b97a614b378fa63bf320b38b-"></script>
<script src="https://www.omicsonline.org/js/jquery.coolfieldset.js" type="b97a614b378fa63bf320b38b-"></script>

<script async src="https://www.googletagmanager.com/gtag/js?id=UA-29271993-2" type="b97a614b378fa63bf320b38b-"></script>
<script type="b97a614b378fa63bf320b38b-">
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-29271993-2');
</script>

<script type="b97a614b378fa63bf320b38b-text/javascript">
_atrk_opts = { atrk_acct:"AQs4j1a4ZP00a6", domain:"omicsonline.org",dynamic: true};
(function() { var as = document.createElement('script'); as.type = 'text/javascript'; as.async = true; as.src = "https://d31qbv1cthcecs.cloudfront.net/atrk.js"; var s = document.getElementsByTagName('script')[0];s.parentNode.insertBefore(as, s); })();
</script>
<noscript>
<img src="https://d5nxst8fruw4z.cloudfront.net/atrk.gif?account=AQs4j1a4ZP00a6" style="display:none" height="1" width="1" alt="alexa"/>
</noscript>

<script type="application/ld+json">
{
  "@context" : "http://schema.org",
  "@type" : "Article",
  "name" : "Intense Therapeutic Ultrasound for Chronic Lateral Epicondylitis Pain Reduction",
  "author" : {
    "@type" : "Person",
    "name" : "Michael H Slayton, John A Kearney, Richard C Amodei and Keegan B Compton"
  },
  "datePublished" : "2018-04-18",
  "url" : "https://www.omicsonline.org/open-access/intense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202.pdf"
}
</script>
<title>Intense Therapeutic Ultrasound for Chronic Lateral Epicondylitis Pain Reduction</title>
<meta name="keywords" content="Intense therapeutic ultrasound; Tennis elbow; Chronic epicondylitis; Epicondylosis; Tendinopathy; Non-invasive therapy; Elbow pain reduction, Ultrasound, Pain, Chronic Lateral Epicondylitis, Therapeutic, omics, open access, omics publishing group, open access publisher, open access publishers, open access publications, open access journals, open access artcles, omics group, omicsonline">
<meta name="description" content="Introduction: Intense therapeutic ultrasound (ITU) is a newly established ultrasound-based, non-invasive therapy in which sound waves are concentrated and focused on musc..">
<link rel="canonical" href="https://www.omicsonline.org/open-access/intense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html"><meta name="citation_publisher" content="OMICS International" />
<meta name="citation_journal_title" content="Journal of Sports Medicine & Doping Studies">
<meta name="citation_title" content="Intense Therapeutic Ultrasound for Chronic Lateral Epicondylitis Pain Reduction">
<meta name="citation_author" content="Michael H Slayton" />
<meta name="citation_author" content="John A Kearney" />
<meta name="citation_author" content="Richard C Amodei" />
<meta name="citation_author" content="Keegan B Compton" />
<meta name="citation_year" content="2018">
<meta name="citation_volume" content="8" />
<meta name="citation_issue" content="2">
<meta name="citation_doi" content="10.4172/2161-0673.1000202">
<meta name="citation_issn" content="2161-0673">
<meta name="citation_publication_date" content="2018/04/18" />
<meta name="citation_firstpage" content="1">
<meta name="citation_lastpage" content="6">
<meta name="citation_fulltext_html_url" content="https://www.omicsonline.org/open-access/intense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html">
<meta name="citation_pdf_url" content="https://www.omicsonline.org/open-access/intense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202.pdf">
<meta name="citation_abstract_html_url" content="https://www.omicsonline.org/peer-reviewed/pintense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reductionp-100794.html" />
<meta name="citation_abstract" content="Introduction: Intense therapeutic ultrasound (ITU) is a newly established ultrasound-based, non-invasive therapy in which sound waves are concentrated and focused on musculoskeletal tissue for the purpose of pain reduction. This technology produces selective thermal coagulative changes over a small controlled area while leaving the surrounding tissue unaffected and without impacting the integrity of the dermis.Methods: A clinical study evaluating 29 patients (Age: 39 &#8211; 60, Male: 59%, Female 41%) for the effectiveness, safety and patient tolerance of Intense Therapeutic Ultrasound (ITU) for treatment of chronic (average length of symptoms prior to treatment: 12.9 months), subcutaneous lateral Epicondylitis musculoskeletal tissue pain reduction was conducted. All patients enrolled in this IRB approved study had been previously diagnosed with Chronic Lateral Epicondylitis and had failed previous Standard-of-Care treatment regimen. Two ITU treatments were administered four weeks apart. Self-reported lateral elbow Universal Visual Analog pain scores and Patient-Rated Tennis Elbow Evaluation pain scores while performing normal daily tasks, were recorded pre-treatment (baseline measurement) and again at each follow-up time point - 4, 8, 12, and 26 weeks - after initial treatment. The goal for all subjects was to reduce overall pain and pain while performing everyday tasks by at least 25% on the average and more than 25% individually. While arbitrary, such criteria appear to be rigorous to reduce standard error and individual selfassessment variability.Results: Successful reduction of overall pain scores at 12 and 26 weeks following the first treatment are 88% and 82% of patients meeting the pain reduction criteria respectively. Also, at the same follow-up time points, patients reported an average VAS Pain Score reduction of 59% (Week 12) and 57% (Week 26) from a pre-treatment average of 5.08 down to an average of 2.2 at week 26. Additionally, patients reported an average pain reduction while performing everyday tasks of 58% and 61% respectively. Patient satisfaction remained over 80% for all follow-up dates.Conclusion: ITU is a promising non-invasive pain relief treatment for cases of chronic lateral epicondylitis." />
<meta property="og:title" content="Intense Therapeutic Ultrasound for Chronic Lateral Epicondylitis Pain Reduction" />
<meta property="og:url" content="https://www.omicsonline.org/open-access/intense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html" />
<meta property="og:description" content="Introduction: Intense therapeutic ultrasound (ITU) is a newly established ultrasound-based, non-invasive therapy in which sound waves are concentrated and focused on musculoskeleta.." />
<meta property="og:site_name" content="OMICS International" />
<meta property="og:image" content="https://www.omicsonline.org/images/journal-logos/Journal-of-Sports-Medicine-&-Doping-Studies-logo.png" />
</head>
<body class="bg-grey-200">

<div class="container">
<div class="row">
<div class="col-12">
<div class="bg-white shadow-3dp">
<div class="bg-blue-900">
<div class="row align-items-center">
<div class="col-xs-12 col-sm-7">
<nav class="nav font-size-13 divided-list">
<a class="nav-link text-white" href="https://www.omicsonline.org/" title="Click Here">Home</a>
<a class="nav-link text-white" href="https://www.omicsonline.org/open-access-journals-list.php" title="Click Here">Publications</a>
<a class="nav-link text-white" href="https://www.omicsonline.org/international-scientific-conferences/" title="Click Here">Conferences </a>
<a class="nav-link text-white" href="https://www.omicsonline.org/register.php" title="Click Here">Join</a>
<a class="nav-link text-white" href="https://www.omicsonline.org/contact.php" title="Click Here">Contact</a>
</nav>
</div>
<div class="col-xs-12 col-sm-5 d-flex justify-content-end">
<nav class="nav font-size-12">
<a href="https://www.omicsonline.org/sitemap.xml" title="Click here" class="nav-link text-white"><i class="fa fa-sitemap" aria-hidden="true"></i></a>
<a href="https://www.facebook.com/omicsinternational" target="_blank" title="Click here" class="nav-link text-white"><i class="fab fa-facebook-f"></i></a>
<a href="https://twitter.com/OMICSJournal" target="_blank" title="Click here" class="nav-link text-white"><i class="fab fa-twitter"></i></a>
<a href="https://www.linkedin.com/company/omics-publishing-group/" target="_blank" title="Click here" class="nav-link text-white"><i class="fab fa-linkedin-in"></i></a>
<a href="https://plus.google.com/+OmicsgroupOrg/" target="_blank" title="Click here" class="nav-link text-white"><i class="fab fa-google-plus-g"></i></a>
<a href="https://www.slideshare.net/OMICSPublishingGroup" target="_blank" title="Click here" class="nav-link text-white"><i class="fab fa-slideshare"></i></a>
<a href="https://www.omicsonline.org/rss/journal-of-sports-medicine-doping-studies.xml" target="_blank" title="Click here" class="nav-link text-white"><i class="fas fa-rss"></i></a>
<a href="https://www.youtube.com/OMICSPublishingGroup" target="_blank" title="Click here" class="nav-link text-white"><i class="fab fa-youtube"></i></a>
</nav>
</div>
</div>
</div>
<div class="p-3">
<div class="row align-items-center">
<div class="col-xs-12 col-sm-2">
<a href="https://www.omicsonline.org/sports-medicine-doping-studies.php" title="Journal of Sports Medicine & Doping Studies"><img src="https://www.omicsgroup.org/articles-admin/headers/Journal-of-Sports-Medicine-&-Doping-Studies-logo.png" class="img-fluid jrnl-logo flex-items-lg-around" alt="Journal of Sports Medicine & Doping Studies" width="100" height="100"></a><br />
ISSN: 2161-0673
</div>
<div class="col-xs-12 col-sm-7">
<h2 class="text-primary">Journal of Sports Medicine &amp; Doping Studies</h2>
</div>
<div class="col-xs-12 col-sm-3">
<form role="search" action="https://www.omicsonline.org/searchresult.php">
<div class="input-group">
<input type="text" name="keyword" required id="keyword" class="form-control" placeholder="Search...">
<span class="input-group-btn">
<input class="btn btn-primary" type="submit" value="search">
</span>
</div>
<script language="javascript" type="b97a614b378fa63bf320b38b-text/javascript">
					$("#keyword").coolautosuggest({
						url: "https://www.omicsonline.org/author-names.php?chars=",
					});
				</script>
</form>
</div>
</div>
</div>
<nav class="navbar navbar-expand-lg navbar-dark bg-primary main-navbar w-100 py-0">
<a class="navbar-brand sr-only" href="#">OMICS</a>
<button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#journalNav" aria-controls="journalNav" aria-expanded="false" aria-label="Toggle navigation">
<span class="navbar-toggler-icon"></span>
</button>
<div class="collapse navbar-collapse justify-content-center" id="journalNav">
<ul class="navbar-nav font-size-12">
<li class="nav-item active">
<a class="nav-link" href="https://www.omicsonline.org/sports-medicine-doping-studies.php" title="Home">Home</a
			></li>
<li class="nav-item dropdown">
<a class="nav-link dropdown-toggle" href="#" id="EditorialPanel" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Editorial Panel</a>
<div class="dropdown-menu" aria-labelledby="EditorialPanel">
<a class="dropdown-item" href="https://www.omicsonline.org/editorinchief-sports-medicine-doping-studies-open-access.php" title="Editor-in-Chief">Editor-in-Chief</a>
<a class="dropdown-item" href="https://www.omicsonline.org/editorialboard-sports-medicine-doping-studies-open-access.php" title="Editorial Board">Editorial Board</a>
</div>
</li>
<li class="nav-item">
<a class="nav-link" href="https://www.omicsonline.org/instructionsforauthors-sports-medicine-doping-studies-open-access.php" title="Instructions for Authors">Instructions for Authors</a>
</li>
<li class="nav-item">
<a class="nav-link" href="https://www.omicsonline.org/submitmanuscript-sports-medicine-doping-studies-open-access.php" title="Submit Manuscript">Submit Manuscript</a>
</li>
<li class="nav-item">
<a class="nav-link" href="https://www.omicsonline.org/ArchiveJSMDS/articleinpress-sports-medicine-doping-studies-open-access.php" title="Articles in press">Articles in press</a>
</li>
<li class="nav-item">
<a class="nav-link" href="https://www.omicsonline.org/ArchiveJSMDS/currentissue-sports-medicine-doping-studies-open-access.php" title="Current Issue">Current Issue</a>
</li>
<li class="nav-item">
<a class="nav-link" href="https://www.omicsonline.org/archive-sports-medicine-doping-studies-open-access.php" title="Current Issue">Archive</a>
</li>
<li class="nav-item dropdown">
<a class="nav-link dropdown-toggle" href="#" id="SpecialIssues" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Special Issues</a>
<div class="dropdown-menu" aria-labelledby="SpecialIssues">
<a class="dropdown-item" href="https://www.omicsonline.org/guidelines-sports-medicine-doping-studies-open-access.php" title="Guidelines">Guidelines</a>
<a class="dropdown-item" href="https://www.omicsonline.org/specialissue-sports-medicine-doping-studies-open-access.php" title="Upcoming Special Issues">Upcoming Special Issues</a>
</div>
</li>
<li class="nav-item">
<a class="nav-link" href="https://www.omicsonline.org/journals-publishing-getting-readers-indexing.php" title="Metrics">Metrics</a>
</li>
<li class="nav-item">
<a class="nav-link" href="https://www.omicsonline.org/contact-sports-medicine-doping-studies-open-access.php" title="Contact">Contact</a>
</li>
</ul>
</div>
</nav> <div class="p-3">
<div class="row">
<div class="col-xs-12 col-sm-9">
<ul class="list-inline divided list font-size-14 grey-800 mb-1">
<li class="list-inline-item ">Research Article&nbsp;&nbsp;<i class="fa fa-caret-right" aria-hidden="true"></i>&nbsp;</li>
<li class="list-inline-item ">
J Sports Med Dop Stud, Vol 8(2) </li>
<li class="list-inline-item "></li>
<li class="list-inline-item">DOI: 10.4172/2161-0673.1000202</li>
</ul>
<article class="full-text">
<h1 class="font-size-26">Intense Therapeutic Ultrasound for Chronic Lateral Epicondylitis Pain Reduction</h1>
<dl class="authors">
<dt class="mb-1  font-weight-normal"><a href="https://www.omicsonline.org/author-profile/michael-h-slayton-264332/" title="Michael H Slayton ">Michael H Slayton</a><sup class="font-weight-normal"><a href="#a1">1</a></sup><sup><a href="#corr264332" style="font-size:13px; color:blue;">*</a></sup>, <a href="https://www.omicsonline.org/author-profile/john-a-kearney-264336/" title="John A Kearney ">John A Kearney</a><sup class="font-weight-normal"><a href="#a2">2</a></sup>, <a href="https://www.omicsonline.org/author-profile/richard-c-amodei-264343/" title="Richard C Amodei ">Richard C Amodei</a><sup class="font-weight-normal"><a href="#a1">1</a></sup><span style='color: rgb(51, 51, 51);font-weight: 400; text-decoration:none'> and </span><a href="https://www.omicsonline.org/author-profile/keegan-b-compton-264345/" title="Keegan B Compton ">Keegan B Compton</a><sup class="font-weight-normal"><a href="#a1">1</a></sup></dt><dd id="a1"><sup>1</sup>Guided Therapy Systems, Inc. 33 S. Sycamore Mesa, Arizona, USA</dd><dd id="a2"><sup>2</sup>The More Foundation, 18444 North 25th Avenue, Phoenix, Arizona, USA</dd></dl>
<div class="mb-1">

<sup style="font-size:13px; color:blue;">*</sup><strong>Corresponding Author:</strong>
<a id="corr264332" name="corr"></a>
Michael H Slayton, Guided Therapy Systems, Inc. 33 S. Sycamore Mesa, Arizona 85202-1150, USA, Tel: +1-480-649-4399, Fax: +1-480-649-1605, Email: <a href="/cdn-cgi/l/email-protection#375a19445b564e4358597750425e535253435f524556474e1954585a" title="m.slayton@guidedtherapy.com"><span class="__cf_email__" data-cfemail="7b165508171a020f14153b1c0e121f1e1f0f131e091a0b0255181416">[email&#160;protected]</span></a>
</div>

<br><br>
<p>
<em>
Received Date: Mar 23, 2018 /
Accepted Date: Apr 05, 2018 /
Published Date: Apr 18, 2018 </em>
</p>
<div class="card card-header mb-1 container-xs center-block text-xs-left">
<h3>Abstract</h3>
<p class="text-justify">
<p><strong>Introduction:</strong> Intense therapeutic ultrasound (ITU) is a newly established ultrasound-based, non-invasive therapy in which sound waves are concentrated and focused on musculoskeletal tissue for the purpose of pain reduction. This technology produces selective thermal coagulative changes over a small controlled area while leaving the surrounding tissue unaffected and without impacting the integrity of the dermis.<br /><strong>Methods:</strong> A clinical study evaluating 29 patients (Age: 39 &#8211; 60, Male: 59%, Female 41%) for the effectiveness, safety and patient tolerance of Intense Therapeutic Ultrasound (ITU) for treatment of chronic (average length of symptoms prior to treatment: 12.9 months), subcutaneous lateral Epicondylitis musculoskeletal tissue pain reduction was conducted. All patients enrolled in this IRB approved study had been previously diagnosed with Chronic Lateral Epicondylitis and had failed previous Standard-of-Care treatment regimen. Two ITU treatments were administered four weeks apart. Self-reported lateral elbow Universal Visual Analog pain scores and Patient-Rated Tennis Elbow Evaluation pain scores while performing normal daily tasks, were recorded pre-treatment (baseline measurement) and again at each follow-up time point - 4, 8, 12, and 26 weeks - after initial treatment. The goal for all subjects was to reduce overall pain and pain while performing everyday tasks by at least 25% on the average and more than 25% individually. While arbitrary, such criteria appear to be rigorous to reduce standard error and individual selfassessment variability.<br /><strong>Results:</strong> Successful reduction of overall pain scores at 12 and 26 weeks following the first treatment are 88% and 82% of patients meeting the pain reduction criteria respectively. Also, at the same follow-up time points, patients reported an average VAS Pain Score reduction of 59% (Week 12) and 57% (Week 26) from a pre-treatment average of 5.08 down to an average of 2.2 at week 26. Additionally, patients reported an average pain reduction while performing everyday tasks of 58% and 61% respectively. Patient satisfaction remained over 80% for all follow-up dates.<br /><strong>Conclusion:</strong> ITU is a promising non-invasive pain relief treatment for cases of chronic lateral epicondylitis.</p> </p>
<p><strong>Keywords:</strong>
Intense therapeutic ultrasound; Tennis elbow; Chronic epicondylitis; Epicondylosis; Tendinopathy; Non-invasive therapy; Elbow pain reduction </p>
</div>
<div class="text-center">
<div class="btn-group mb-1" role="group" aria-label=""> <a class="btn btn-outline-warning" href="https://www.omicsonline.org/open-access/intense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202.pdf" title="Click here"><i aria-hidden="true" class="fa fa-file-pdf-o"></i> View PDF</a> <a class="btn btn-outline-warning" href="https://www.omicsonline.org/pdfdownload.php?download=open-access/intense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202.pdf&aid=100794" title="Click here"><i aria-hidden="true" class="fa fa-file-pdf-o"></i> Download PDF</a>
</div>
</div>

<h4>Introduction</h4> <div class='text-justify'><p>Intense therapeutic ultrasound (ITU) is a newly established ultrasound based therapy in which high frequency sound waves are focused into designated musculoskeletal tissue [<a title="1" href="#1">1</a>-<a title="4" href="#4">4</a>]. This produces selective thermal coagulative changes over a small controlled volume (0.3 &#8211; 0.5 mm<sup>3</sup>) while leaving the surrounding tissue unaffected and without impacting the integrity of the <a href="https://www.omicsonline.org/dermatitis.php" target="_blank">dermis</a>. These coagulative changes are known to begin the body&#8217;s tissue response cascade and promote collagen generation in the targeted anatomy resulting in <a href="https://www.omicsonline.org/pain-relief.php" target="_blank">pain</a> reduction [<a title="5" href="#5">5</a>-<a title="7" href="#7">7</a>]. ITU has been used clinically to treat the subcutaneous musculoskeletal tissue below facial skin for the past decade and it has received CE Mark and FDA 510(k) clearance to market for nonsurgical brow and submental tissue lifting. Over 3 Million patients worldwide have been treated using this technology. <a href="https://www.omicsonline.org/clinical-diagnosis-research.php" target="_blank">Clinical</a> studies have shown that 85% of patients receiving this treatment on facial skin tissue showed an improvement in facial lifting with no erythema, inflammation or scarring by creating the same coagulative changes to the connective tissue under the skin [<a title="1" href="#1">1</a>-<a title="4" href="#4">4</a>]. Histologically, it has been shown that ITU induces the production of dermal collagen with thickening of the dermis and straightening of the elastic fibers in the reticular dermis [<a title="1" href="#1">1</a>-<a title="4" href="#4">4</a>]. Previous research in laboratory studies has shown that ITU can improve healing of damaged Achilles tendons in a rabbit model. Laboratory studies have shown that ITU can improve healing of damaged Achilles tendons in both a rabbit and rat model [<a title="5" href="#5">5</a>-<a title="7" href="#7">7</a>]. Preliminary results showed an increase in precursor markers for collagen regeneration (e.g. VEGFa, TNF&#945;, IL-1&#946;, and TGF&#946;1) and subsequent increase in collagen formation in injured rabbit tendons treated with ITU compared to injured, untreated rabbit tendons [<a title="5" href="#5">5</a>-<a title="7" href="#7">7</a>]. This study applied ITU to human subcutaneous musculoskeletal <a href="https://www.omicsonline.org/tissue-science-engineering.php" target="_blank">tissue</a> to determine if this technology will begin the same collagen regeneration response to reduce pain within these chronic, degenerative structures.</p>
<p>Acute and Chronic pain of the Common Extensor Tendon (CET) region, or lateral epicondylitis/lateral epicondylalgia, or tennis elbow is a common <a href="https://www.omicsonline.org/diagnostic-pathology.php" target="_blank">pathology</a> of both athletes and non-athletes affecting 1 to 3% of the population at large [<a title="8" href="#8">8</a>]. While the prevalence of chronic problems caused by overuse in tennis players can be as high as 40%; elbow tendinopathy represents an important set of pathologies that account for lost recreation time, decreased quality of life, and workrelated disability claims. As an example, medial and lateral epicondylitis was responsible for 11.7% of work-related injury claims in Washington State from 1987 to 1995, resulting in an average direct workers&#8217; compensation cost of $6,593 per case [<a title="9" href="#9">9</a>]. Elbow tendinopathy has widespread social, financial, and clinical implications. Walker- Bone et al. [<a title="10" href="#10">10</a>] assessed the significant effect of medial and lateral epicondylitis on workplace absences in a cross-sectional sample of 9,696 working-aged adults.</p>
<p>A single-blinded, pivotal study evaluating the effectiveness, safety and patient tolerance for the use of Intense Therapeutic Ultrasound (ITU) as a treatment to reduce pain in patients diagnosed with chronic lateral epicondylitis was completed at The More Foundation/CORE Institute in Phoenix, AZ. A total 29 patients received 2 treatments, 4 weeks apart on subcutaneous musculoskeletal tissues along with Standard of Care treatments as prescribed by the Principal Investigator. Patients were followed for up to 6 months after the first treatment receiving a physical exam at each follow-up visit (at 4, 8, and 12 weeks) and providing feedback via standardized Visual Analog Scale (VAS)[8] for overall pain, Patient/Subject Reported Outcome Measure (SROM) [<a title="11" href="#11">11</a>] and Patient-Rated Tennis Elbow Evaluation (PRTEE) surveys specific lateral epicondylitis [<a title="8" href="#8">8</a>]. The objective of this study is to reduce pain by at least 25% compared to the baseline during the follow-up period.</p></div>
<h4>Materials and Methods</h4> <div class='text-justify'><p><strong>Materials</strong></p>
<p>ITU treatments administered using the Actisound System - Intense Therapeutic Ultrasound by Guided Therapy Systems, Inc. (Mesa, AZ, USA). Diagnostic ultrasound images <strong>(Figure 1)</strong> were acquired on a SparkTM system manufactured by Ardent Sound, Inc. (Mesa, AZ, USA).</p>
<div class="card card-block card-header mb-2">
<div class="row flex-items-xs-middle">
<div class="col-xs-12 col-sm-2 col-md-3"><a href="https://www.omicsonline.org/publication-images/sports-medicine-doping-studies-ultrasound-8-202-g001.png" target="_blank"><img class="media-object img-fluid" title="sports-medicine-doping-studies-ultrasound" src="https://www.omicsonline.org/publication-images/sports-medicine-doping-studies-ultrasound-8-202-g001.png" alt="sports-medicine-doping-studies-ultrasound" /></a></div>
<div class="col-xs-12 col-sm-10 col-md-9">
<p><strong>Figure 1:</strong> Diagnostic ultrasound images. LE: Lateral Epicondyle; RH: Radial Head; CET: Common Extensor Tendon (Red Arrows); FL; Fluid (Visit 1); RFL: Resolving Fluid (Visit 4).</p>
</div>
</div>
</div>
<p>All treatments and diagnostic ultrasound images were performed by trained personnel.</p>
<p><strong>Inclusion/exclusion criteria</strong></p>
<p>Subjects previously diagnosed with lateral epicondylitis and were experiencing unilateral chronic pain (&gt;90 days) after standard-of-care regimens, usually involving a multifactorial approach that may include a combination of rest (complete or modified activity), medication (NSAIDs for Epicondylitis), stretching and strength training [<a title="11" href="#11">11</a>], failed to relieve pain on the lateral elbow were included in the study. Patients had been experiencing symptoms for an average of 12.9 months &#8211; with a range of 3 &#8211; 24 months. Only 3 patients were experiencing symptoms from 3 &#8211; 6 months. In many cases, patients had previously undergone more aggressive therapy regimens, i.e., tenotomy, Platelet Rich Plasma (PRP) and/or cortisone injections &#8211; all of which had failed to reduce pain for an extended period of time. Subjects provided both written and verbal consent as well as willingness to complete treatment and post-treatment regimen as prescribed. Those included in the study did not have a history of surgery to the area of interest or participate in any alternative treatments within the last 90 days.</p>
<p>Patients concurrently enrolled in any other non-conservative, device, or Investigational New Drug clinical trial, or who have participated in a clinical study involving the Common Extensor <a href="http://www.imedpub.com/scholarly/muscletendon--ligaments-journals-articles-ppts-list.php" target="_blank">Tendon</a> (CET), thirty days prior to study initiation and patients who have received previous treatment in the symptomatic limb (not including conservative treatment) were excluded from the study. Also, at the principal investigator&#8217;s discretion, subjects were excluded based on their current condition or medical history.</p>
<p><strong>Treatment</strong></p>
<p>Subjects underwent 2 treatments; the first at their baseline assessment, Visit 1, Week 0, and the second at Visit 3, Week 4. A series of ultrasound pulses, ranging from 80-200 in total with an energy level of 1 joule (1J) were administered to the lateral epicondyle, approximately 4-6 mm below the skin line, for each treatment. After treatment, patients engaged in additional standard care remedies from home, including ice packs and stretching, and logged the frequency of these.</p>
<p><strong>Measurements</strong></p>
<p><strong>Pain level: </strong>Overall pain level at the CET was self-reported by subjects at pre-treatment (used as baseline measurement) and again at each follow-up - 4, 8, 12, and 26 weeks - after initial treatment. The Visual Analog Score (VAS) pain scale subjects used to identify their level of pain was a 10-point pain scale range, where 0=no pain, 1=slight pain through 10 which equates to the patient&#8217;s worst imaginable pain.</p>
<p><strong>Patient rated tennis elbow evaluation score:</strong> Patients self-reported answers to questions from the Patient Rated Tennis Elbow Evaluation (PRTEE) questionnaire, which has been standardized for use in research studies to evaluate patient&#8217;s level of pain and function [<a title="8" href="#8">8</a>]. Scores range from 0-100, with 0 indicating no pain and 100 indicating the worst pain imaginable in a variety of daily activities involving use of the CET. Self-reported scores were taken at baseline and each follow-up time point.</p>
<p><strong>SROMs, patient satisfaction and treatment pain:</strong> Self-Reported Outcome Measures (SROMs) [<a title="9" href="#9">9</a>,<a title="11" href="#11">11</a>] assessing each patients&#8217; progress were completed during each follow-up time point. The questions pertained to patients&#8217; assessments of overall personal improvement compared to baseline tracked on a 3-point scale, pain reduction compared to baseline tracked on a 4-point scale, percentage change in elbow pain, change in pain compared to baseline tracked on a 5-point scale, and percentage change in daily activities compared to baseline. Overall Patient Satisfaction was also tracked using a patient reported 4-point scale [<a title="10" href="#10">10</a>-<a title="12" href="#12">12</a>]: Totally Satisfied, Satisfied with Minor Reservations, Satisfied with Major Reservations, and Dissatisfied. Using the same Universal VAS pain scale, patient tolerance for the treatment was evaluated and their post-treatment experience as it relates to treatment&#8217;s safety.</p>
<p><strong>Statistical analysis</strong></p>
<p>Both VAS pain scores and PRTEE scores reported at follow-up time points were compared to their corresponding baseline scores for each subject to determine if the goal was met by dividing the difference of the two by the baseline pain score. The percentage of subjects that met the pain reduction goal was calculated at each time point by dividing the number of subjects that achieved the pain reduction goal at each time point by the total number of patients that gave a pain score for that time point.</p>
<p>Student T-tests were utilized to determine statistically significant differences between baseline and subsequent follow-up measurements for self-reported measurements. All error bars displayed in graphs are standard error. The level of significance (&#945;) was set to 0.05.</p></div>
<h4>Results</h4> <div class='text-justify'><p><strong>Patient population and attrition</strong></p>
<p><strong>Table 1</strong> shows the statistics of the study group. 29 Patients were included in this study; 12 females and 17 males. The age range of the study group was 39-60 years old, with a median age of 46. The number of patients declined slightly over the course of the study due to attrition, with 29 patients at week 4, 26 patients at week 8, 25 patients at week 12, and 22 patients at week 26.</p>
<div class="table-responsive">
<table class="table table-sm table-bordered">
<thead>
<tr>
<th>The More Foundation, Common Extensor Tendon</th>
<th>Baseline</th>
<th>Week 4</th>
<th>Week 8</th>
<th>Week 12</th>
<th>Week 26</th>
</tr>
</thead>
<tbody>
<tr>
<td>Number of Patients</td>
<td>29</td>
<td>29</td>
<td>26</td>
<td>25</td>
<td>22</td>
</tr>
<tr>
<td>Age, Years, Baseline (range)</td>
<td colspan="5">46 (39-60)</td>
</tr>
<tr>
<td>Average No. of Months, Symptomatic, (Range)</td>
<td colspan="5">12.9 Months (3 &#8211; 24) with 3 patients, less than 6 months</td>
</tr>
<tr>
<td>Gender, M/F, (%)</td>
<td colspan="5">17 (58.6%) / 12 (41.4%)</td>
</tr>
</tbody>
</table>
</div>
<p><strong>Table 1:</strong> Patient population and statistics.</p>
<p><strong>Pain score reduction</strong></p>
<p><strong>Table 2</strong> shows the number of patients at each of the baseline selfreported VAS pain scores. At each follow-up time point, the number of responding patients and the number of patients meeting the individual criteria of higher than 25% pain reduction from the baseline are shown. A majority of patients met or exceeded the criteria of 25% pain reduction according to the self-reported VAS pain score, up to 88% at week 12.</p>
<div class="table-responsive">
<table class="table table-sm table-bordered">
<thead>
<tr>
<th>Baseline Pain Score</th>
<th>Baseline N at each pain score</th>
<th>No. of Patients assessed at 4 weeks</th>
<th>No. of Patients meeting primary pain criteria at 4 weeks</th>
<th>No. of Patients assessed at 8 weeks</th>
<th>No. of Patients meeting primary pain criteria at 8 weeks</th>
<th>No. of Patients assessed at 12 weeks</th>
<th>No. of Patients meeting primary pain criteria at 12 weeks</th>
<th>No. of Patients assessed at 26 weeks</th>
<th>No. of Patients meeting primary pain criteria at 26 weeks</th>
</tr>
</thead>
<tbody>
<tr>
<td>10</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>9</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>8</td>
<td>5</td>
<td>5</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>4</td>
</tr>
<tr>
<td>7</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>1</td>
<td>1</td>
<td>2</td>
<td>2</td>
</tr>
<tr>
<td>6</td>
<td>6</td>
<td>6</td>
<td>6</td>
<td>6</td>
<td>4</td>
<td>6</td>
<td>6</td>
<td>6</td>
<td>5</td>
</tr>
<tr>
<td>5</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>1</td>
<td>2</td>
<td>2</td>
<td>1</td>
<td>1</td>
</tr>
<tr>
<td>4</td>
<td>7</td>
<td>7</td>
<td>5</td>
<td>5</td>
<td>4</td>
<td>5</td>
<td>4</td>
<td>4</td>
<td>3</td>
</tr>
<tr>
<td>3</td>
<td>4</td>
<td>4</td>
<td>2</td>
<td>4</td>
<td>3</td>
<td>4</td>
<td>3</td>
<td>3</td>
<td>2</td>
</tr>
<tr>
<td>2</td>
<td>3</td>
<td>3</td>
<td>3</td>
<td>3</td>
<td>2</td>
<td>3</td>
<td>2</td>
<td>2</td>
<td>1</td>
</tr>
<tr>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Total</td>
<td>29</td>
<td>29</td>
<td>24</td>
<td>26</td>
<td>20</td>
<td>25</td>
<td>22</td>
<td>22</td>
<td>18</td>
</tr>
<tr>
<td colspan="2">% Meeting Criteria</td>
<td>&#160;</td>
<td>68%</td>
<td>&#160;</td>
<td>77%</td>
<td>&#160;</td>
<td>88%</td>
<td>&#160;</td>
<td>82%</td>
</tr>
</tbody>
</table>
</div>
<p><strong>Table 2:</strong> Patient reported pain scores by visit and % meeting pain reduction criteria.</p>
<p><strong>Figure 2</strong> shows a highly significant drop in average reported pain score (VAS) for all time points compared to baseline (p &lt; 0.001), dropping below half the original baseline average by week 12. The blue bars represent the average reported pain score at baseline and at each follow-up timepoint. The Gold Bars show the average percent pain score reduction at each follow-up time point, compared to baseline.</p>
<div class="card card-block card-header mb-2">
<div class="row flex-items-xs-middle">
<div class="col-xs-12 col-sm-2 col-md-3"><a href="https://www.omicsonline.org/publication-images/sports-medicine-doping-studies-reduction-8-202-g002.png" target="_blank"><img class="media-object img-fluid" title="sports-medicine-doping-studies-reduction" src="https://www.omicsonline.org/publication-images/sports-medicine-doping-studies-reduction-8-202-g002.png" alt="sports-medicine-doping-studies-reduction" /></a></div>
<div class="col-xs-12 col-sm-10 col-md-9">
<p><strong>Figure 2:</strong> Average pain score and &amp; pain reduction by visit (p &#8804; 0.001) standard error noted.</p>
</div>
</div>
</div>
<p><strong>PRTEE score reduction</strong></p>
<p>In <strong>Figure 3</strong>, the blue bars show the average reported pain score based on normal daily activities at baseline and at each follow-up timepoint. There is significant reduction when compared to baseline (p&lt;0.001 for all follow-up dates). The gold bars demonstrate a % reduction from baseline is cut by approximately 60% by week 12 and continuing to week 26.</p>
<div class="card card-block card-header mb-2">
<div class="row flex-items-xs-middle">
<div class="col-xs-12 col-sm-2 col-md-3"><a href="https://www.omicsonline.org/publication-images/sports-medicine-doping-studies-score-8-202-g003.png" target="_blank"><img class="media-object img-fluid" title="sports-medicine-doping-studies-score" src="https://www.omicsonline.org/publication-images/sports-medicine-doping-studies-score-8-202-g003.png" alt="sports-medicine-doping-studies-score" /></a></div>
<div class="col-xs-12 col-sm-10 col-md-9">
<p><strong>Figure 3:</strong> Average standardized PRTEE score by visit (p &#8804; 0.001) standard error noted.</p>
</div>
</div>
</div>
<p><strong>SROMs</strong></p>
<p><strong>Table 3</strong> shows the results of SROMs answered by patients at each timepoint. At every timepoint following the second treatment (Week 4), a majority of patients felt better and experienced at least a 25% improvement in pain and daily activities. The proportion of patients that felt improvement in these categories increased at each subsequent timepoint. The table shows the percentage of patients that met each criterion in the Self-Reported survey.</p>
<div class="table-responsive">
<table class="table table-sm table-bordered">
<thead>
<tr>
<th rowspan="3">&#160;</th>
<th colspan="6">Self-Reported Outcome Measures (SROM) Questionnaire by Week</th>
</tr>
<tr>
<th colspan="6">Compared to my initial visit</th>
</tr>
<tr>
<th>&#160;</th>
<th>"I feel better"</th>
<th>"I have no/less pain"</th>
<th>"&gt;25% improvement in Elbow pain"</th>
<th>"Elbow pain is much/all better"</th>
<th>"&gt;25% improvement in Daily Activities"</th>
</tr>
<tr>
<td rowspan="4">Patients</td>
<td>Week 4</td>
<td>66%</td>
<td>69%</td>
<td>48%</td>
<td>41%</td>
<td>45%</td>
</tr>
<tr>
<td>Week 8</td>
<td>69%</td>
<td>73%</td>
<td>54%</td>
<td>65%</td>
<td>54%</td>
</tr>
<tr>
<td>Week 12</td>
<td>80%</td>
<td>80%</td>
<td>72%</td>
<td>56%</td>
<td>72%</td>
</tr>
<tr>
<td>Week 26</td>
<td>87%</td>
<td>77%</td>
<td>73%</td>
<td>68%</td>
<td>73%</td>
</tr>
<tr>
<td>&#160;</td>
</tr>
</thead>
</table>
</div>
<p><strong>Table 3:</strong> Patient self-reported outcome measure (RROMSs) by week.</p>
<p><strong>Patient satisfaction</strong></p>
<p>Self-Reported Overall Patient Satisfaction was tracked on a 4-point scale. Patients meeting the satisfaction criteria either reported that they were totally satisfied or satisfied with minor reservations. At each follow-up time point patient satisfaction, based on these criteria was between 76% and 97% (Gold Bars). Additionally, we tracked those patients reporting satisfaction, with major reservations (White Bars). <strong>Figure 4</strong> shows patient satisfaction was recorded between 80% and 100%.</p>
<div class="card card-block card-header mb-2">
<div class="row flex-items-xs-middle">
<div class="col-xs-12 col-sm-2 col-md-3"><a href="https://www.omicsonline.org/publication-images/sports-medicine-doping-studies-satisfaction-8-202-g004.png" target="_blank"><img class="media-object img-fluid" title="sports-medicine-doping-studies-satisfaction" src="https://www.omicsonline.org/publication-images/sports-medicine-doping-studies-satisfaction-8-202-g004.png" alt="sports-medicine-doping-studies-satisfaction" /></a></div>
<div class="col-xs-12 col-sm-10 col-md-9">
<p><strong>Figure 4:</strong> Percentage of patients meeting satisfaction criteria.</p>
</div>
</div>
</div>
<p><strong>Treatment pain</strong></p>
<p>No anesthetic or analgesic was used during the ITU treatments. For treatment 1, the average pain score was 4.9; 84% of patients reported average pain scores of 4.3 and a range of 0-8, while 16% had momentary and infrequent pain score spikes up to 10. No patients interrupted treatment due to intolerable pain during the first round of treatments. For treatment 2, the average pain score was 4.7; 83% of patients reported average pain scores of 4.1 and a range of 0-8, while 17% had momentary and infrequent pain score spikes up to 10. No patients interrupted treatment due to intolerable pain during the rounds of treatments and no attrition was associated with treatment pain.</p></div>
<h4>Discussion</h4> <div class='text-justify'><p>The results of this study correlate well with the findings of the facial musculoskeletal studies [<a title="1" href="#1">1</a>-<a title="4" href="#4">4</a>] and other musculoskeletal studies currently utilizing ITU.</p>
<p>Based on the results of our study, intense therapeutic ultrasound (ITU) has potential to become a widely used treatment for chronic tennis elbow. Having statistically significant reduction on both pain and functional limitations within the first 4 weeks and maintaining that reduction through 26 weeks; demonstrates solid evidence that ITU can be effective for treating tennis elbow and possibly other musculoskeletal conditions. In fact, we&#8217;ve achieved similar results in other study centers focusing on the treatment of <a href="https://www.omicsonline.org/scholarly/plantal-fasciitis-surgery-journals-articles-ppts-list.php" target="_blank">plantar fasciitis</a> using the same ITU technology [<a title="13" href="#13">13</a>]. Using ITU for the treatment of various tendinopathies, like the two conditions listed above, is favorable due to superficial nature of the injury. With the scale of target depth being millimeters, this allows energy-based technologies to remain a noninvasive treatment options for those patients whom conventional treatment options remain ineffective and do not wish to have surgery.</p>
<p>Extracorporeal shockwave treatment (ESWT) is a very different ultrasound-based technology that has been used as a <a href="https://www.omicsonline.org/scholarly/invasive-and-noninvasive-procedure-journals-articles-ppts-list.php" target="_blank">non-invasive</a> musculoskeletal treatment. In literature, ESWT has achieved mixed results with the treatment of tennis elbow and is reported to be extremely painful during and after treatment. A study performed by Crowther MAA et al. comparing ESWT and steroid injection showed a significant difference in pain reduction favoring steroid injection after 3 months; in addition, the same study provided an estimation of treatment cost to patients to be 100-fold for the ESWT method over injection [<a title="12" href="#12">12</a>]. Another study by Haake M et al. studying the sideeffects of ESWT treatment for tennis elbow said that treatment pain was the second-most frequent side-effect after skin reddening and significantly more frequently than the placebo group [<a title="14" href="#14">14</a>]. ESWTtreatment regimens vary in several studies, between 2000-3000 pulses most commonly [<a title="11" href="#11">11</a>,<a title="13" href="#13">13</a>-<a title="15" href="#15">15</a>]. With treatment frequency around 120-240 pulses per minute, this means treatments last around 10-30 minutes. In comparison, ITU treatments for our study lasted less than 2 minutes, while achieving significant improvement in pain reduction and return to normal activity.</p>
<p>Injections are a commonly used method of treatment for tennis elbow, yet long term success is varied with this choice depending on the type of injection. The Crowther MAA et al. study found more success using steroid injections over ESWT, though this study extended only to 3-months from treatment [<a title="12" href="#12">12</a>]. Platelet-rich plasma injections have had mixed success, one study showing significantly differing success from control only at 24 weeks [<a title="16" href="#16">16</a>] while another study had a significant difference from an autologous blood injection only in the short-term of 6 weeks [<a title="9" href="#9">9</a>] Injections of sodium hyaluronate have been explored as a possible treatment due to the highly preserved structure and biocompatibility of hyaluronan (HA) and its role in the lubrication of tissues in the body. Results of a study by Petrella et al. show significant difference between HA-treated individuals and the control group in both pain reduction and grip strength at 12 months beyond treatment [<a title="17" href="#17">17</a>].</p>
<p>Tenotomy is another method of treatment that is considered minimally invasive requiring the patient to be locally anesthetized. Though success rates are high in the long-term, recovery can be a length process; for example, a study performed by Koh et al. showed that tendon thickness and echogenicity took 6 months to return to normal levels following their tenotomy procedure [<a title="18" href="#18">18</a>]. The same findings with hypoechoic scar tissue resolving itself after 6 months in 90% of patients were found in a study performed by Seng et al. [<a title="19" href="#19">19</a>]. Despite the longer recovery period, tenotomy has had high levels of success across many studies in both pain reduction and patient satisfaction [<a title="20" href="#20">20</a>-<a title="23" href="#23">23</a>].</p></div>
<h4>Conclusion</h4> <div class='text-justify'><p>This study has shown the effectiveness, safety and patient tolerability of ITU therapy for pain relief and improved function for patients suffering from chronic lateral epicondylitis. Patients reported an average of 57% reduction in Pain Scores (VAS) and an 80% overall treatment satisfaction at 26 weeks. Considering all patients were diagnosed with chronic tennis elbow, and previous standard of care treatment options had failed to reduce pain or improve daily function, ITU for chronic <a href="https://www.omicsonline.org/scholarly/musculoskeletal-system-journals-articles-ppts-list.php" target="_blank">musculoskeletal</a> pain could be considered as an important tool for the treatment of chronic tennis elbow. Furthermore, patient-reported satisfaction and return-of-function for the affected area further provide evidence for the potential ITU has for becoming a non-invasive, patient-friendly treatment that requires no down time allowing patients to return to their normal activities within weeks.</p></div>
<h4>Funding</h4> <div class='text-justify'><p>Guided Therapy Systems funded this study. No additional financial support was received by the authors for the work completed in this submission.</p></div>
<h4>References</h4> <div class='text-justify'><ol>
<li id="Reference_Titile_Link" value="1"><a id="1" name="1"></a>White MW, Makin IR, Barthe PB, Slayton MH, Gliklich RE (2007)<a title="Click here" href="https://doi.org/10.1001/archfaci.9.1.22" target="_blank"> Selective Creation of Thermal Injury Zones in the Superficial Musculoaponeurotic System Using Intense Ultrasound Therapy A New Target for Noninvasive Facial Rejuvenation. Arch Facial Plastic Surgery 9: 22-29.</a></li>
<li id="Reference_Titile_Link" value="2"><a id="2" name="2"></a>Alam M, White LE, Martin N, Witherspoon J, Yoo S, et al. (2010)<a title="Click here" href="https://doi.org/10.1016/j.jaad.2009.06.039" target="_blank"> Ultrasound Tightening of Facial and Neck Skin: A Rater-Blinded Prospective Cohort Study. J Am Acad Dermatol 62: 262-269.</a></li>
<li id="Reference_Titile_Link" value="3"><a id="3" name="3"></a>Gliklich RE, White WM, Slayton MH, Barthe PG, Makin IR (2007)<a title="Click here" href="https://doi.org/10.1001/archfaci.9.2.88" target="_blank"> Clinical Pilot Study of Intense Ultrasound Therapy to Deep Dermal Facial Skin and Subcutaneous Tissues. Arch Facial Plast Surg 9: 88-95.</a></li>
<li id="Reference_Titile_Link" value="4"><a id="4" name="4"></a>Laubach HA, Makin IR, Barthe PG, Slayton MH, Manstein D (2008)<a title="Click here" href="https://doi.org/10.1111/j.1524-4725.2008.34196.x" target="_blank"> Intense Focused Ultrasound: Evaluation of a New Treatment Modality for Precise Microcoagulation within the Skin. DermatolSurg 34: 727-734.</a></li>
<li id="Reference_Titile_Link" value="5"><a id="5" name="5"></a>Slayton MH, Barton JK (2014)<a title="Click here" href="https://onlinelibrary.wiley.com/doi/pdf/10.1002/lsm.22229" target="_blank"> Feasibility of Modulating Healing Tissue Response by ITU (Intense Therapy Ultrasound) in Musculoskeletal Tissue. American Society for Laser Medicine and Surgery Abstracts.</a></li>
<li id="Reference_Titile_Link" value="6"><a id="6" name="6"></a>Barton JK, Rice PF, Howard CC, Koevary JW, Danford FL, et al. (2018)<a title="Click here" href="https://doi.org/10.1117/12.2288525" target="_blank"> Structural and Functional Assessment of Intense Therapeutic Ultrasound Effects on Partial Achilles Tendon Transection. Proceedings in Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems.</a></li>
<li id="Reference_Titile_Link" value="7"><a id="7" name="7"></a>Molloy T, Wang Y, Murrell GAC (2003)<a title="Click here" href="https://doi.org/10.2165/00007256-200333050-00004" target="_blank"> The Roles of Growth Factors in Tendon and Ligament Healing. Sports Med 33: 381-394.</a></li>
<li id="Reference_Titile_Link" value="8"><a id="8" name="8"></a>Rompe JD, Overend TJ, MacDermid JC (2007)<a title="Click here" href="https://doi.org/10.1197/j.jht.2006.10.003" target="_blank"> Validation of the Patient-rated Tennis Elbow Evaluation Questionnaire. J Hand Ther 20: 3-10.</a></li>
<li id="Reference_Titile_Link" value="9"><a id="9" name="9"></a>Thanasas C, Papadimitriou G, Charalambidis C, Paraskevopoulos I, Papanikolaou A (2011)<a title="Click here" href="https://doi.org/10.1177/0363546511417113" target="_blank"> Platelet-Rich Plasma Versus Autologous Whole Blood for the Treatment of Chronic Lateral Elbow Epicondylitis: A Randomized Controlled Clinical Trial. Am J Sports Med 39: 2130-2134.</a></li>
<li id="Reference_Titile_Link" value="10"><a id="10" name="10"></a>Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C (2004)<a title="Click here" href="https://doi.org/10.1002/art.20535" target="_blank"> Prevalence and Impact of Musculoskeletal Disorders of the Upper Limb in the General Population. Arthritis Rheum 51: 642-651.</a></li>
<li id="Reference_Titile_Link" value="11"><a id="11" name="11"></a>DiGiovanni BF, Nawoczenski DA, Lintal ME, Moore EA, Murray JC, et al. (2003)<a title="Click here" href="https://doi.org/10.2106/00004623-200307000-00013" target="_blank"> Tissue-Specific Plantar Fascia-Stretching Exercise Enhances Outcomes in Patients with Chronic Heel Pain. A Prospective, Randomized Study. J Bone Joint Surg Am 85: 1270-1277.</a></li>
<li id="Reference_Titile_Link" value="12"><a id="12" name="12"></a>Crowther MA, Bannister GC, Huma H, Rooker GD (2002)<a title="Click here" href="https://doi.org/10.1302/0301-620x.84b5.0840678" target="_blank"> A prospective, Randomized Study to compare Extracorporeal Shock-Wave Therapy and Injection of Steroid for the Treatment of Tennis Elbow. J Bone Joint Ther 84: 678-679.</a></li>
<li id="Reference_Titile_Link" value="13"><a id="13" name="13"></a>Slayton MH, Amodei RC, Compton KB, Latt D, Kearny J (2016)<a title="Click here" href="https://doi.org/10.1109/HIC.2016.7797733" target="_blank"> Musculoskeletal Treatments using Intense Therapy Ultrasound: Clinical Studies for Chronic Plantar Fasciitis and Lateral Epicondylitis. IEEE Healthcare Innovation Point-Of-Care Technologies Conference (HI-POCT).</a></li>
<li id="Reference_Titile_Link" value="14"><a id="14" name="14"></a>Haake M, B&#246;ddeker IR, Decker T, Buch M, Vogel M, et al. (2002)<a title="Click here" href="https://doi.org/10.1007/s00402-001-0362-7" target="_blank"> Side-effects of Extracorporeal Shock Wave Therapy (ESWT) in the Treatment of tennis elbow. Arch Orthop Trauma Surg 122: 222-228.</a></li>
<li id="Reference_Titile_Link" value="15"><a id="15" name="15"></a>G&#252;nd&#252;z R, Malas F&#220;, Borman P, Kocao&#287;lu S, &#214;z&#231;akar L (2012)<a title="Click here" href="https://doi.org/10.1007/s10067-012-1939-y" target="_blank"> Physical Therapy, Corticosteroid Injection, and Extracorporeal Shock Wave Treatment in Lateral Epicondylitis: Clinical and Ultrasonographical Comparison. Clin Rheumatol 31: 807-812.</a></li>
<li id="Reference_Titile_Link" value="16"><a id="16" name="16"></a>Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, et al. (2013)<a title="Click here" href="https://doi.org/10.1177/0363546513494359" target="_blank"> Efficacy of Platelet-Rich Plasma for Chronic Tennis Elbow: A Double-Blind, Prospective, Multicenter, Randomized Controlled Trial of 230 Patients. Am J Sports Med 42: 463-471.</a></li>
<li id="Reference_Titile_Link" value="17"><a id="17" name="17"></a>Petrella RJ, Cogliano A, Decaria J, Mohamed N, Lee R (2010)<a title="Click here" href="https://doi.org/10.1186/1758-2555-2-4" target="_blank"> Management of Tennis Elbow with Sodium HyaluronatePeriarticular Injections. Sports Med ArthroscRehabilTherTechnol 2: 4.</a></li>
<li id="Reference_Titile_Link" value="18"><a id="18" name="18"></a>Koh JS, Mohan PC, Howe TS, Lee BP, Chia SL, et al. (2013)<a title="Click here" href="https://doi.org/10.1177/0363546512470625" target="_blank"> Fasciotomy and Surgical Tenotomy for Recalcitrant Lateral Elbow Tendinopathy: Early Clinical Experience With a Novel Device for Minimally Invasive Percutaneous Microresection. Am J Sports Med 41: 636-644.</a></li>
<li id="Reference_Titile_Link" value="19"><a id="19" name="19"></a>Seng C, Mohan PC, Koh SB, Howe TS, Lim YG, et al. (2015)<a title="Click here" href="https://doi.org/10.1177/0363546515612758" target="_blank"> Ultrasonic Percutaneous Tenotomy for Recalcitrant Lateral Elbow Tendinopathy: Sustainability and Sonographic Progression at 3 Years. Am J Sports Med 44: 504-510.</a></li>
<li id="Reference_Titile_Link" value="20"><a id="20" name="20"></a>Barnes DE, Beckley JM, Smith J (2015)<a title="Click here" href="https://doi.org/10.1016/j.jse.2014.07.017" target="_blank"> Percutaneous Ultrasonic Tenotomy for Chronic Elbow Tendinosis: A Prospective Study. J Shoulder Elbow Surg 24: 67-73.</a></li>
<li id="Reference_Titile_Link" value="21"><a id="21" name="21"></a>Tasto JP, Richmond JM, Cummings JR, Hardesty R, Amiel D (2016)<a title="Click here" href="https://doi.org/10.1016/j.arthro.2014.04.059" target="_blank"> Radiofrequency Microtenotomy for Elbow Epicondylitis: Midterm Results. Am J Orthop (Belle Mead NJ) 45: 29-33.</a></li>
<li id="Reference_Titile_Link" value="22"><a id="22" name="22"></a>Tasto JP, Cummings J, Medlock V, Hardesty R, Amiel D (2005)<a title="Click here" href="https://doi.org/10.1016/j.arthro.2005.03.019" target="_blank"> Microtenotomy Using a Radiofrequency Probe to Treat Lateral Epicondylitis. Arthroscopy 21: 851-860.</a></li>
<li id="Reference_Titile_Link" value="23"><a id="23" name="23"></a>Solheim E, Hegna J, &#216;yen J (2013)<a title="Click here" href="https://doi.org/10.1016/j.arthro.2012.12.012" target="_blank"> Arthroscopic Versus Open Tennis Elbow Release: 3- to 6-Year Results of a Case-Control Series of 305 Elbows. Arthroscopy 29: 854-859.</a></li>
</ol></div>
<div id="citation-btn" class="card card-block card-header mb-1">
<p class="card-text">
<span class="fweight-600">Citation: </span>
Slayton MH, Kearney JA, Amodei RC, Compton KB (2018) Intense Therapeutic Ultrasound for Chronic Lateral Epicondylitis Pain Reduction. J Sports Med Doping Stud 8: 202. Doi: 10.4172/2161-0673.1000202 </p>
<p class="card-text"><span class="fweight-600">Copyright: </span>&#169; 2018 Slayton MH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.</p>
</div>
</article>
</div>

<div class="col-xs-12 col-sm-3">
<div class="card mb-3">
<div class="card-body p-1">
<p class="card-text">Select your language of interest to view the total content in your interested language</p>
<div id="google_translate_element" align="center" style="width:180px;"></div>
<script data-cfasync="false" src="/cdn-cgi/scripts/f2bf09f8/cloudflare-static/email-decode.min.js"></script><script type="b97a614b378fa63bf320b38b-">
												function googleTranslateElementInit() {
														new google.translate.TranslateElement({
														pageLanguage: 'en'
														}, 'google_translate_element');
												}
										</script>
<script src="https://translate.google.com/translate_a/element.js?cb=googleTranslateElementInit" type="b97a614b378fa63bf320b38b-"></script>
</div>
</div>
<a href="#post" class="btn btn-success btn-block btn-3d mb-1">Post Your Comment</a>
<a href="#citation-btn" class="btn btn-primary btn-block btn-3d mb-1">Citation</a>

<div class="divider-v6 mb-1">
<div class="divider-v6-element divider-v6-element-left before-after-bg-orange">
<h5 class="divider-v6-element-title divider-v6-element-title-brd orange-900 brd-color-orange"> Share This Article </h5>
</div>
<ul class="list-inline sidebar-soc text-xs-center py-05">
<li><a class="soc-facebook" href="https://rest.sharethis.com/v1/share/share?destination=facebook&api_key=5ffe4e56-22bc-43ba-b939-67ecb59ff6c5&url=https%3A%2F%2Fwww.omicsonline.org%2Fopen-access%2Fintense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html%3Faid%3D100794&title=Intense+Therapeutic+Ultrasound+for+Chronic+Lateral+Epicondylitis+Pain+Reduction" target="_blank" rel="nofollow" title="Share with Facebook"></a></li>
<li><a class="soc-twitter" href="https://rest.sharethis.com/v1/share/share?destination=twitter&api_key=5ffe4e56-22bc-43ba-b939-67ecb59ff6c5&url=https%3A%2F%2Fwww.omicsonline.org%2Fopen-access%2Fintense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html%3Faid%3D100794&title=Intense+Therapeutic+Ultrasound+for+Chronic+Lateral+Epicondylitis+Pain+Reduction" target="_blank" rel="nofollow" title="Share with Twitter"></a></li>
<li><a class="soc-linkedin" href="https://rest.sharethis.com/v1/share/share?destination=linkedin&api_key=5ffe4e56-22bc-43ba-b939-67ecb59ff6c5&url=https%3A%2F%2Fwww.omicsonline.org%2Fopen-access%2Fintense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html%3Faid%3D100794&title=Intense+Therapeutic+Ultrasound+for+Chronic+Lateral+Epicondylitis+Pain+Reduction" target="_blank" rel="nofollow" title="Share with Linkdin"></a></li>
<li><a class="soc-googleplus" href="https://rest.sharethis.com/v1/share/share?destination=googleplus&api_key=5ffe4e56-22bc-43ba-b939-67ecb59ff6c5&url=https%3A%2F%2Fwww.omicsonline.org%2Fopen-access%2Fintense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html%3Faid%3D100794&title=Intense+Therapeutic+Ultrasound+for+Chronic+Lateral+Epicondylitis+Pain+Reduction" target="_blank" rel="nofollow" title="Share with Google+"></a></li>
<li><a class="soc-pinterest" href="https://rest.sharethis.com/v1/share/share?destination=pinterest&api_key=5ffe4e56-22bc-43ba-b939-67ecb59ff6c5&url=https%3A%2F%2Fwww.omicsonline.org%2Fopen-access%2Fintense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html%3Faid%3D100794&title=Intense+Therapeutic+Ultrasound+for+Chronic+Lateral+Epicondylitis+Pain+Reduction" rel="nofollow" target="_self" title="Share with Pintrest"></a></li>
<li><a class="soc-blogger soc-icon-last" href="https://rest.sharethis.com/v1/share/share?destination=blogger&api_key=5ffe4e56-22bc-43ba-b939-67ecb59ff6c5&url=https%3A%2F%2Fwww.omicsonline.org%2Fopen-access%2Fintense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html%3Faid%3D100794&title=Intense+Therapeutic+Ultrasound+for+Chronic+Lateral+Epicondylitis+Pain+Reduction" target="_blank" rel="nofollow" title="Share with Blogger"></a></li>
</ul>
</div>

<div class="divider-v6 mb-1">
<div class="divider-v6-element divider-v6-element-left before-after-bg-orange">
<h5 class="divider-v6-element-title divider-v6-element-title-brd orange-900 brd-color-orange"> Relevant Topics </h5>
</div>


<nav class="nav glyph-arrow-right max-height-500 scrollbar">
<a class="nav-link" href="https://www.omicsonline.org/scholarly/advanced-osteoporosis-treatment-journals-articles-ppts-list.php" title="Advanced Osteoporosis Treatment">Advanced Osteoporosis Treatment</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/aerobics--fitness-journals-articles-ppts-list.php" title="Aerobics & Fitness">Aerobics & Fitness</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/alcoholism--osteoporosis-risk-journals-articles-ppts-list.php" title="Alcoholism & Osteoporosis Risk">Alcoholism & Osteoporosis Risk</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/alternative-treatment--of-osteoporosis-journals-articles-ppts-list.php" title="Alternative Treatment  of Osteoporosis">Alternative Treatment of Osteoporosis</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/cancer-rehabilitation-journals-articles-ppts-list.php" title="Cancer Rehabilitation">Cancer Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/cardiopulmonary-rehabilitation-journals-articles-ppts-list.php" title="Cardiopulmonary Rehabilitation">Cardiopulmonary Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/cardiovascular-disability--rehabilitation-journals-articles-ppts-list.php" title="Cardiovascular Disability">Cardiovascular Disability</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/clinical-physical-medicine--rehabilitation-journals-articles-ppts-list.php" title="Clinical Physical Medicine & Rehabilitation">Clinical Physical Medicine & Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/common-sports-injuries-journals-articles-ppts-list.php" title="Common Sports Injuries">Common Sports Injuries</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/exercise-physiology-journals-articles-ppts-list.php" title="Exercise Physiology">Exercise Physiology</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/geriatric-rehabilitation-journals-articles-ppts-list.php" title="Geriatric Rehabilitation">Geriatric Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/hospice-and-palliative-medication-journals-articles-ppts-list.php" title="Hospice and Palliative Medication">Hospice and Palliative Medication</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/idiopathic-osteoporosis-journals-articles-ppts-list.php" title="Idiopathic Osteoporosis">Idiopathic Osteoporosis</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/inpatient-rehabilitation-journals-articles-ppts-list.php" title="Inpatient Rehabilitation">Inpatient Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/interventional-pain--physical-medicine-journals-articles-ppts-list.php" title="Interventional Pain">Interventional Pain</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/mental-rehabilitation-journals-articles-ppts-list.php" title="Mental Rehabilitation">Mental Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/musculoskeletal-pain-management-journals-articles-ppts-list.php" title="Musculoskeletal Pain Management">Musculoskeletal Pain Management</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/neuromuscular-medicine-journals-articles-ppts-list.php" title="Neuromuscular Medicine">Neuromuscular Medicine</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/neurophysiology-journals-articles-ppts-list.php" title="Neurophysiology">Neurophysiology</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/orthopedic-rehabilitation-journals-articles-ppts-list.php" title="Orthopedic Rehabilitation">Orthopedic Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/orthopedic-surgery-and-sports-medicine-journals-articles-ppts-list.php" title="Orthopedic Surgery and Sports Medicine">Orthopedic Surgery and Sports Medicine</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/osteoarthritis-journals-articles-ppts-list.php" title="Osteoarthritis">Osteoarthritis</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/osteomalacia-journals-articles-ppts-list.php" title="Osteomalacia">Osteomalacia</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/osteomyelitis-journals-articles-ppts-list.php" title="Osteomyelitis">Osteomyelitis</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/osteopenia-journals-articles-ppts-list.php" title="Osteopenia">Osteopenia</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/osteoporosis-journals-articles-ppts-list.php" title="Osteoporosis">Osteoporosis</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/osteoporosis-in-women-journals-articles-ppts-list.php" title="Osteoporosis in Women">Osteoporosis in Women</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/osteosarcoma-journals-articles-ppts-list.php" title="Osteosarcoma">Osteosarcoma</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/pain-mechanisms-journals-articles-ppts-list.php" title="Pain Mechanisms">Pain Mechanisms</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/pathophysiology-of-osteoporosis-journals-articles-ppts-list.php" title="Pathophysiology of Osteoporosis">Pathophysiology of Osteoporosis</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/pediatric-rehabilitation-journals-articles-ppts-list.php" title="Pediatric Rehabilitation">Pediatric Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/pediatric-sports-medicine-journals-articles-ppts-list.php" title="Pediatric Sports Medicine">Pediatric Sports Medicine</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/physical-activity-journals-articles-ppts-list.php" title="Physical Activity">Physical Activity</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/physical-medicine-and-rehabilitation-journals-articles-ppts-list.php" title="Physical Medicine and Rehabilitation">Physical Medicine and Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/physical-therapist-communications-journals-articles-ppts-list.php" title="Physical Therapist Communications">Physical Therapist Communications</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/postmanupasual-osteoproisis-journals-articles-ppts-list.php" title="Postmanupasual Osteoproisis">Postmanupasual Osteoproisis</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/primary-care-sports-medicine-journals-articles-ppts-list.php" title="Primary Care Sports Medicine">Primary Care Sports Medicine</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/rehabilitation-nursing-journals-articles-ppts-list.php" title="Rehabilitation Nursing">Rehabilitation Nursing</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/rehabilitation-services--market-analysis-journals-articles-ppts-list.php" title="Rehabilitation Services">Rehabilitation Services</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/rehabilitation-therapy-journals-articles-ppts-list.php" title="Rehabilitation Therapy">Rehabilitation Therapy</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/spinal-cord-injury-medicine--rehabilitation-journals-articles-ppts-list.php" title="Spinal Cord Injury Medicine">Spinal Cord Injury Medicine</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-injury-prevention-journals-articles-ppts-list.php" title="Sports Injury Prevention">Sports Injury Prevention</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-management-journals-articles-ppts-list.php" title="Sports Management">Sports Management</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-medicine-journals-articles-ppts-list.php" title="Sports Medicine">Sports Medicine</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-medicine-blogs-journals-articles-ppts-list.php" title="Sports Medicine Blogs">Sports Medicine Blogs</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-medicine-case-reports-journals-articles-ppts-list.php" title="Sports Medicine Case Reports">Sports Medicine Case Reports</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-medicine-nurse-practisioner-journals-articles-ppts-list.php" title="Sports Medicine Nurse Practisioner">Sports Medicine Nurse Practisioner</a>
 <a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-medicine-practice-journals-articles-ppts-list.php" title="Sports Medicine Practice">Sports Medicine Practice</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-medicine-rehabilitation-journals-articles-ppts-list.php" title="Sports Medicine Rehabilitation">Sports Medicine Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-medicine-and-fitness-journals-articles-ppts-list.php" title="Sports Medicine and Fitness">Sports Medicine and Fitness</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-psychology--journals-articles-ppts-list.php" title="Sports Psychology">Sports Psychology</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-therapy-journals-articles-ppts-list.php" title="Sports Therapy">Sports Therapy</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-and-exercise-medicine-journals-articles-ppts-list.php" title="Sports and Exercise Medicine">Sports and Exercise Medicine</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/sports-science-journals-articles-ppts-list.php" title="Sports science">Sports science</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/steroidinduced-osteoporosis-journals-articles-ppts-list.php" title="Steroid-induced Osteoporosis">Steroid-induced Osteoporosis</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/surgical-rehabilitation-journals-articles-ppts-list.php" title="Surgical Rehabilitation">Surgical Rehabilitation</a>
<a class="nav-link" href="https://www.omicsonline.org/scholarly/traumatic-brain-injuries-tbi-journals-articles-ppts-list.php" title="Traumatic Brain Injuries (TBI)">Traumatic Brain Injuries (TBI)</a>
</nav>
</div>

<div class="divider-v6 mb-1">
<div class="divider-v6-element divider-v6-element-left before-after-bg-orange">
<h5 class="divider-v6-element-title divider-v6-element-title-brd orange-900 brd-color-orange"> Recommended Journals </h5>
</div>
<ul class="nav glyph-arrow-right max-height-200 scrollbar">
<li class="nav-item"><a class="nav-link" href="http://www.mhfmjournal.com/" title="Family Medicine" target="_blank">Family Medicine</a></li>
<li class="nav-item"><a class="nav-link" href="https://www.omicsonline.org/osteoporosis-and-physical-activity.php" title="Osteoporosis Journal" target="_self">Osteoporosis Journal</a></li>
<li class="nav-item"><a class="nav-link" href="https://www.omicsonline.org/physical-medicine-rehabilitation.php" title="Physical Medicine Journal" target="_self">Physical Medicine Journal</a></li>
</ul>
<a href="https://www.omicsonline.org/open-access-journals-list.php" class="viewmore font-italic font-weight-bold" title="Click here">Viewmore</a>
</div>

<div class="divider-v6 mb-1">
<div class="divider-v6-element divider-v6-element-left before-after-bg-orange">
<h6 class="divider-v6-element-title divider-v6-element-title-brd orange-900 brd-color-orange"> Recommended Conferences </h6>
</div>
<ul class="list-group conferences max-height-250 scrollbar">
<li class="list-group-item list-group-item-action">
<h6 class="list-group-item-heading">11th World Congress on <a href="http://annualmeeting.conferenceseries.com/orthopedicians/">Orthopedics, Rheumatology &amp; Sports Medicine</a></h6>
<p class="list-group-item-text">July 09-11, 2018 Sydney, Australia</p>
</li>
<li class="list-group-item list-group-item-action">
<h6 class="list-group-item-heading">International Conference on <a href="https://sportsmedicine.conferenceseries.com/">Sports Medicine and Doping Studies</a></h6>
<p class="list-group-item-text">October 24-25, 2018 Osaka Japan</p>
</li>
<li class="list-group-item list-group-item-action">
<h6 class="list-group-item-heading">International Conference on <a href="https://kinesiology.conferenceseries.com/">Kinesiology and Biomechanics</a></h6>
<p class="list-group-item-text">October 24-25, 2018 Osaka Japan</p>
</li>
<li class="list-group-item list-group-item-action">
<h6 class="list-group-item-heading">4th International Conference on <a href="https://sports.conferenceseries.com/">Sports Medicine and Fitness</a></h6>
<p class="list-group-item-text">November 14-16, 2018 Edinburgh USA</p>
</li>
</ul>
<a href="https://www.omicsonline.org/pharma-conferences.php
" class="viewmore font-italic font-weight-bold" title="Click here" target="_blank">Viewmore</a>
</div>

<div class="divider-v6 mb-1">
<div class="divider-v6-element divider-v6-element-left before-after-bg-orange">
<h6 class="divider-v6-element-title divider-v6-element-title-brd orange-900 brd-color-orange"> Article Tools </h6>
</div>
<ul class="nav glyph-arrow-right">
<li class="nav-item"> <a class="nav-link" href="https://www.omicsgroup.org/citations/export-citations.php?doi=10.4172/2161-0673.1000202" target="_blank" title="Click here">Export citation</a> </li>
<li class="nav-item"> <a class="nav-link" href="https://www.omicsgroup.org/blog-this-article/index.php?doi=10.4172/2161-0673.1000202" title="Click here" target="_blank">Share/Blog this article</a> </li>
</ul>
</div>

<div class="divider-v6 mb-1">
<div class="divider-v6-element divider-v6-element-left before-after-bg-orange">
<h6 class="divider-v6-element-title divider-v6-element-title-brd orange-900 brd-color-orange"> Article Usage </h6>
</div>
<ul class="list-group">
<li class="list-group-item">Total views: <span class="tag tag-warning tag-pill float-xs-right">
378 </span></li>
<li class="list-group-item"> [From(publication date): 0-2018 - Jun 24, 2018] </li>
<li class="list-group-item list-group-item-info"> Breakdown by view type </li>
<li class="list-group-item">HTML page views: <span class="tag tag-warning tag-pill float-xs-right">347</span></li>
<li class="list-group-item">PDF downloads: <span class="tag tag-warning tag-pill float-xs-right">31</span></li>
</ul>
</div>
</div>
</div>


<script src="https://ajax.googleapis.com/ajax/libs/jquery/2.2.4/jquery.min.js" type="b97a614b378fa63bf320b38b-"></script>
<script language="javascript" type="b97a614b378fa63bf320b38b-">
						$(document).ready(function()
						{
						$("#comment_form").submit(function()
						{
						$(".error").hide();
						var hasError = false;
						//var emailReg = /^([\w-\.]+@([\w-]+\.)+[\w-]{2,4})?$/;

						 var com_name=$("#com_name").val();
						 var com_email=$("#com_email").val();
						 var comments=$("#comments").val();
						 var captcha=$("#captcha").val();
						 var journal=$("#journal").val();			 

						$("#msgbox1").html('<img src="https://www.omicsonline.org/images/wait.gif" alt="Wait" width="128" height="15"/><br> <font color="green">Loading Please wait....</font>').fadeIn(1000);
						//check the username exists or not from ajax
						$.post("https://www.omicsonline.org/article-comment-postings.php",{ art_id:100794,journal:$('#journal').val(),com_name:$('#com_name').val(),com_email:$('#com_email').val(),comments:$('#comments').val(),captcha:$('#captcha').val(),rand:Math.random() } ,function(data)
						{
						  if(data=='yes') //if correct login detail
						  {
							$("#msgbox1").fadeTo(200,0.8,function()  //start fading the messagebox
							{ 
							  $(this).html('<font color="green">Thank you for submitting your comments. It will be displayed soon.</font>').addClass('messageboxok').fadeTo(3000,1,
							  //add message and change the class of the box and start fading
							  //$(this).html('Logging in ,Please wait...').addClass('messageboxok').fadeTo(900,1,
							  function()
							  { 
								 //redirect to secure page
								 $(this).html('<font color="green">Thank you for submitting your comments. It will be displayed soon.</font>').addClass('messageboxerror').fadeTo(900,1);
								 								 document.location='https://www.omicsonline.org/open-access/intense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html';
							  }
							  );

							});
						  }
						  else 
						  {
							$("#msgbox1").fadeTo(200,0.1,function() //start fading the messagebox
							{ 
							  //add message and change the class of the box and start fading
							  $(this).html('<font color="red">The Validation code does not match..!</font>').addClass('messageboxerror').fadeTo(900,1);
							});		
						  }

						});
						return false; //not to post the  form physically
						}); 
						});
						</script>
<script type="b97a614b378fa63bf320b38b-text/javascript">
						function refreshCaptcha()
						{
						var img = document.images['captchaimg'];
						img.src = img.src.substring(0,img.src.lastIndexOf("?"))+"?rand="+Math.random()*1000;
						}
						</script>
<a id="post"></a>
<div class="row px-3">


<div class="col-12">
<p class="h4 text-primary border-bottom-1 pb-05 brd-color-orange">Post your comment</p>
<div id="msgbox1" align="center" style="font-size:13px; padding:3px; display:none;"></div>
<form role="form" method="post" id="comment_form" action="">
<input type="hidden" class="form-control" name="journal" id="journal" value="jsmds">
<div class="form-group row">
<label for="Name" class="col-xs-12 col-sm-2 col-form-label">Name: <span class="text-danger">*</span></label>
<div class="col-xs-12 col-sm-4">
<input type="text" class="form-control" name="com_name" id="com_name" value="" placeholder="Enter Your Name" required>
</div>
<label for="E-mail" class="col-xs-12 col-sm-2 col-form-label">E-mail: <span class="text-danger">*</span></label>
<div class="col-xs-12 col-sm-4">
<input type="email" class="form-control" name="com_email" id="com_email" value="" required placeholder="Enter Your E-mail">
</div>
</div>
<div class="form-group row">
<label for="E-mail" class="col-xs-12 col-sm-2 col-form-label">Your comment: <span class="text-danger">*</span></label>
<div class="col-xs-12 col-sm-10">
<textarea class="form-control" id="comments" name="comments" rows="3" placeholder="Type Your Message Here" required></textarea>
</div>
</div>
<div class="form-group row">
<label for="Anti Spam Code" class="col-xs-12 col-sm-2 col-form-label">Anti Spam Code: <span class="text-danger">*</span></label>
<div class="col-xs-12 col-sm-4">
<input type="text" class="form-control" id="captcha" name="captcha" value="" required style="width:100px; font-weight:bold; color:#003399; text-align:center; font-size:14px;" maxlength="6">
<img src="captcha_code_file.php?rand=1356498475" id='captchaimg' align="absmiddle" alt="captcha"> &nbsp;&nbsp;<a href='javascript: refreshCaptcha();'><img src="https://www.omicsonline.org/images/refresh.jpg" width="24" height="24" align="absmiddle" border="0" alt="Reload" title="Reload"></a>&nbsp;&nbsp;Can't read the image? <a href='javascript: refreshCaptcha();' title="Click here">click here</a> to refresh
</div>
</div>
<div class="form-group row">
<div class="offset-sm-2 col-sm-10">
<input type="submit" name="submit" value="Post your comment" class="btn btn-primary">
</div>
</div>
</form>
</div>
</div>

</div>
</div>
</div>
</div>
</div>

<footer>
<div class="container py-1">
<p class="h4 text-white mb-1">Contact Us</p>
<div class="row content-grid no-gutters">
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Agri & Aquaculture Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Dr. Krish</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:agriaquaculture@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="4e2f293c272f3f3b2f2d3b223a3b3c2b0e2123272d3d21202227202b602d2123">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> +1-702-714-7001 <span>Extn: 9040</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Biochemistry Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Datta A</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:biochemjournals@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="0e6c67616d666b6364617b7c606f627d4e6163676d7d61606267606b206d6163">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9037</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Business & Management Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Ronald</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:business@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="93f1e6e0fafdf6e0e0d3fcfefaf0e0fcfdfffafdf6bdf0fcfe">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9042</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Chemistry Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Gabriel Shaw</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:chemistryjournals@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="1b78737e7672686f696271746e69757a77685b747672786874757772757e35787476">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9040</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Clinical Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Datta A</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:clinicaljournals@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="2e4d424740474d4f4244415b5c404f425d6e4143474d5d41404247404b004d4143">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9037</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Engineering Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> James Franklin</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:engineeringjournals@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="b8ddd6dfd1d6ddddcad1d6dfd2d7cdcad6d9d4cbf8d7d5d1dbcbd7d6d4d1d6dd96dbd7d5">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9042</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Food & Nutrition Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Katie Wilson</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:nutritionjournals@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="432d3637312a372a2c2d292c36312d222f30032c2e2a20302c2d2f2a2d266d202c2e">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9042</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">General Science</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Andrea Jason</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:generalscience@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="82e5e7ece7f0e3eef1e1ebe7ece1e7c2edefebe1f1edeceeebece7ace1edef">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9043</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Genetics & Molecular Biology Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Anna Melissa</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:geneticsmolbio@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="bcdbd9d2d9c8d5dfcfd1d3d0ded5d3fcd3d1d5dfcfd3d2d0d5d2d992dfd3d1">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9006</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Immunology & Microbiology Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> David Gorantl</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:immunomicrobiol@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="51383c3c243f3e3c3832233e33383e3d113e3c3832223e3f3d383f347f323e3c">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9014</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Materials Science Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Rachle Green</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:materialsci@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="b1dcd0c5d4c3d8d0ddc2d2d8f1dedcd8d2c2dedfddd8dfd49fd2dedc">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9039</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Medical Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Nimmi Anna</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:medicaljournals@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="d9b4bcbdb0bab8b5b3b6acabb7b8b5aa99b6b4b0baaab6b7b5b0b7bcf7bab6b4">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9038</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Neuroscience & Psychology Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Nathan T</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:neuropsychology@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="c1afa4b4b3aeb1b2b8a2a9aeadaea6b881aeaca8a2b2aeafada8afa4efa2aeac">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9041</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Nursing & Health Care Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Stephanie Skinner</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:nursinghealthcare@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="84eaf1f6f7edeae3ece1e5e8f0ece7e5f6e1c4ebe9ede7f7ebeae8edeae1aae7ebe9">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9039</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Pharmaceutical Sciences Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Ann Jose</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:pharmajournals@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="80f0e8e1f2ede1eaeff5f2eee1ecf3c0efede9e3f3efeeece9eee5aee3efed">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9007</span></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-3 content-grid-item p-0 address-group">
<div class="card equal-height-1 font-size-14">
<div class="card-body p-2">
<h6 class="card-title mb-0 orange-500">Social & Political Science Journals</h6>
<ul class="list-unstyled card-text mb-0">
<li><span class="fa fa-user orange-500"></span> Steve Harry</li>
<li><span class="fa fa-envelope-o orange-500"></span> <a href="mailTo:social_politicalsci@omicsonline.com" title="Click Here">
<span class="__cf_email__" data-cfemail="1d6e727e747c71426d72717469747e7c716e7e745d7270747e6e727371747378337e7270">[email&#160;protected]</span> </a></li>
<li><span class="fa fa-phone orange-500"></span> 1-702-714-7001 <span>Extn: 9042</span></li>
</ul>
</div>
</div>
</div>
</div>
<p class="text-center text-white"> &copy; 2008-2018 <a href="https://www.omicsonline.org/" title="OMICS International" style="color:#FFF; text-decoration:underline;">OMICS International</a> - Open Access Publisher.</p>
</div>
</footer>


<a href="javascript:void(0);" class="js-back-to-top back-to-top-theme"></a>


<script data-cfasync="false" src="/cdn-cgi/scripts/f2bf09f8/cloudflare-static/email-decode.min.js"></script><script src="https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js" type="b97a614b378fa63bf320b38b-"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/tether/1.3.7/js/tether.min.js" type="b97a614b378fa63bf320b38b-"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0-alpha.5/js/bootstrap.min.js" type="b97a614b378fa63bf320b38b-"></script>
<script type="b97a614b378fa63bf320b38b-text/javascript" src="https://www.omicsonline.org/js/jquery.back-to-top.js"></script>
<script src="https://www.omicsonline.org/js/jquery.equal-height.js" type="b97a614b378fa63bf320b38b-"></script>
<script src="https://www.omicsonline.org/js/equal-height.js" type="b97a614b378fa63bf320b38b-"></script>
<script src="https://www.omicsonline.org/js/jquery.mCustomScrollbar.concat.min.js" type="b97a614b378fa63bf320b38b-"></script>
<script src="https://www.omicsonline.org/js/scrollbar.js" type="b97a614b378fa63bf320b38b-"></script>

<a id="chat" class="btn p-0 border-0 rounded-0 leave-your-message font-size-20 white d-flex flex-column text-center fweight-600" data-toggle="modal" data-target="#leaveAMessage" style="transform: rotate(90deg); transform-origin: 90% 30%;"> <span class="px-1" style="background-color: #185fa1; text-shadow: 1px 1px 1px #666;">Leave Your Message</span> <span style="background-color: #ff5a00;"><i class="fas fa-envelope"></i> 24x7 <i class="fas fa-phone-volume"></i></span> </a>


<div class="modal fade" id="leaveAMessage" tabindex="-1" role="dialog" aria-labelledby="leaveAMessagelLabel" aria-hidden="true">
<div class="modal-dialog modal-lg" role="document">
<form role="form" id="leavemessage_form" name="leavemessage_form" action="" method="post">
<div class="modal-content">
<div class="modal-header">
<h3 class="modal-title text-center" id="leaveAMessageLabel"> Journal of Sports Medicine & Doping Studies </h3>
<button type="button" class="close" data-dismiss="modal" aria-label="Close"> <span aria-hidden="true">&times;</span> </button>
</div>
<div class="modal-body">
<div class="container-fluid">
<div class="row">
<div class="col">
<p class="text-center text-success"><strong>Please leave a message, we will get back you shortly.</strong></p>
<div id="msgbox2" align="center" class="text-center text-success" style="display:none;"></div>
<input type="hidden" class="form-control" name="journal" id="journal" value="jsmds">
<input type="hidden" class="form-control" name="art_id" id="art_id" value="100794">
<div class="form-group">
<label for="lm_name">Name</label>
<input class="form-control" name="lm_name" id="lm_name" placeholder="Enter Name" required type="name">
</div>
<div class="form-group">
<label for="lm_email">Email</label>
<input class="form-control" name="lm_email" id="lm_email" placeholder="Enter Email" required type="email">
</div>
<div class="form-group">
<label for="lm_phone">Mobile Number</label>
<input class="form-control" name="lm_phone" id="lm_phone" placeholder="Enter Mobile Number" required type="text">
</div>
<div class="form-group">
<label for="lm_country">Country</label>
<select class="form-control" name="lm_country" id="lm_country" required>
<option value="">Select country</option>
<option value="Afghanistan"> Afghanistan</option>
<option value="Albania"> Albania</option>
<option value="Algeria"> Algeria</option>
<option value="American Samoa"> American Samoa</option>
<option value="Andorra"> Andorra</option>
<option value="Angola"> Angola</option>
<option value="Anguilla"> Anguilla</option>
<option value="Antarctica"> Antarctica</option>
<option value="Antigua and Barbuda"> Antigua and Barbuda</option>
<option value="Argentina"> Argentina</option>
<option value="Armenia"> Armenia</option>
<option value="Aruba"> Aruba</option>
<option value="Australia"> Australia</option>
<option value="Austria"> Austria</option>
<option value="AZ USA"> AZ USA</option>
<option value="Azerbaijan"> Azerbaijan</option>
<option value="Bahamas"> Bahamas</option>
<option value="Bahrain"> Bahrain</option>
<option value="Bangladesh"> Bangladesh</option>
<option value="Barbados"> Barbados</option>
<option value="Belarus"> Belarus</option>
<option value="Belgium"> Belgium</option>
<option value="Belize"> Belize</option>
<option value="Benin"> Benin</option>
<option value="BENIN Republic"> BENIN Republic</option>
<option value="Bermuda"> Bermuda</option>
<option value="Bhutan"> Bhutan</option>
<option value="Bolivia"> Bolivia</option>
<option value="Bosnia"> Bosnia</option>
<option value="Bosnia and Herzegovina"> Bosnia and Herzegovina</option>
<option value="Botswana"> Botswana</option>
<option value="Bouvet Island"> Bouvet Island</option>
<option value="Brasil"> Brasil</option>
<option value="Brazil"> Brazil</option>
<option value="British Indian Ocean Territory"> British Indian Ocean Territory</option>
<option value="British Virgin Islands"> British Virgin Islands</option>
<option value="Brunei"> Brunei</option>
<option value="Brunei Darussalam"> Brunei Darussalam</option>
<option value="Bulgaria"> Bulgaria</option>
<option value="Burkina Faso"> Burkina Faso</option>
<option value="Burma"> Burma</option>
<option value="Burundi"> Burundi</option>
<option value="Cambodia"> Cambodia</option>
<option value="Cameroon"> Cameroon</option>
<option value="Canada"> Canada</option>
<option value="Cape Verde"> Cape Verde</option>
<option value="Cayman Islands"> Cayman Islands</option>
<option value="Central Africa"> Central Africa</option>
<option value="Central African Republic"> Central African Republic</option>
<option value="Chad"> Chad</option>
<option value="Chile"> Chile</option>
<option value="China"> China</option>
<option value="Christmas Island"> Christmas Island</option>
<option value="CO USA"> CO USA</option>
<option value="Colombia"> Colombia</option>
<option value="Comoros"> Comoros</option>
 <option value="Congo"> Congo</option>
<option value="Cook Islands"> Cook Islands</option>
<option value="Costa Rica"> Costa Rica</option>
<option value="Cote D'Ivoire"> Cote D'Ivoire</option>
<option value="Croatia"> Croatia</option>
<option value="Cuba"> Cuba</option>
<option value="Curacao"> Curacao</option>
<option value="Cyprus"> Cyprus</option>
<option value="Czech Republic"> Czech Republic</option>
<option value="Democratic Republic of Congo"> Democratic Republic of Congo</option>
<option value="Democratic Republic of the Congo"> Democratic Republic of the Congo</option>
<option value="Denmark"> Denmark</option>
<option value="Djibouti"> Djibouti</option>
<option value="Dominica"> Dominica</option>
<option value="Dominican Republic"> Dominican Republic</option>
<option value="DR Congo"> DR Congo</option>
<option value="Ecuador"> Ecuador</option>
<option value="Egypt"> Egypt</option>
<option value="El Salvador"> El Salvador</option>
<option value="England"> England</option>
<option value="Equatorial Guinea"> Equatorial Guinea</option>
<option value="Eritrea"> Eritrea</option>
<option value="Espana"> Espana</option>
<option value="Estonia"> Estonia</option>
<option value="Ethiopia"> Ethiopia</option>
<option value="Falkland Islands"> Falkland Islands</option>
<option value="Faroe Islands"> Faroe Islands</option>
<option value="Fiji"> Fiji</option>
<option value="Finland"> Finland</option>
<option value="France"> France</option>
<option value="French Guiana"> French Guiana</option>
<option value="French Polynesia"> French Polynesia</option>
<option value="French Southern Territories"> French Southern Territories</option>
<option value="Gabon"> Gabon</option>
<option value="Gambia"> Gambia</option>
<option value="Georgia"> Georgia</option>
<option value="Germany"> Germany</option>
<option value="Ghana"> Ghana</option>
<option value="Gibraltar"> Gibraltar</option>
<option value="Greece"> Greece</option>
<option value="Greenland"> Greenland</option>
<option value="Grenada"> Grenada</option>
<option value="Guadeloupe"> Guadeloupe</option>
<option value="Guam"> Guam</option>
<option value="Guatemala"> Guatemala</option>
<option value="Guinea"> Guinea</option>
 <option value="Guinea-Bissau"> Guinea-Bissau</option>
<option value="Guyana"> Guyana</option>
<option value="Haiti"> Haiti</option>
<option value="Heard Island"> Heard Island</option>
<option value="Honduras"> Honduras</option>
<option value="Hong Kong"> Hong Kong</option>
<option value="Hong Kong SAR"> Hong Kong SAR</option>
<option value="Hungary"> Hungary</option>
<option value="Iceland"> Iceland</option>
<option value="India"> India</option>
<option value="Indonesia"> Indonesia</option>
<option value="Iran"> Iran</option>
<option value="Iraq"> Iraq</option>
<option value="Ireland"> Ireland</option>
<option value="Islamic Republic of Iran"> Islamic Republic of Iran</option>
<option value="Islamic Republic of Pakistan"> Islamic Republic of Pakistan</option>
<option value="Israel"> Israel</option>
<option value="Isreal"> Isreal</option>
<option value="Italy"> Italy</option>
<option value="Ivory Coast"> Ivory Coast</option>
<option value="Jamaica"> Jamaica</option>
<option value="Japan"> Japan</option>
<option value="Jordan"> Jordan</option>
<option value="Kazakhstan"> Kazakhstan</option>
<option value="Kenya"> Kenya</option>
<option value="Kingdom of Bahrain"> Kingdom of Bahrain</option>
<option value="Kingdom of Saudi Arabia"> Kingdom of Saudi Arabia</option>
<option value="Kingdom of the Netherlands"> Kingdom of the Netherlands</option>
<option value="Kiribati"> Kiribati</option>
<option value="Korea"> Korea</option>
<option value="Korea"> Korea</option>
<option value="Korea, Rep"> Korea, Rep</option>
<option value="Kosova"> Kosova</option>
<option value="Kosovo"> Kosovo</option>
<option value="KSA"> KSA</option>
<option value="Kurdistan"> Kurdistan</option>
<option value="Kuwait"> Kuwait</option>
<option value="Kyrgyzstan"> Kyrgyzstan</option>
<option value="Laos"> Laos</option>
<option value="Latvia"> Latvia</option>
<option value="Lebanon"> Lebanon</option>
<option value="Lesotho"> Lesotho</option>
<option value="Liberia"> Liberia</option>
<option value="Libya"> Libya</option>
<option value="Libyan Arab Jamahiriya"> Libyan Arab Jamahiriya</option>
<option value="Liechtenstein"> Liechtenstein</option>
<option value="Lithuania"> Lithuania</option>
 <option value="Luxembourg"> Luxembourg</option>
<option value="Macao"> Macao</option>
<option value="Macedonia"> Macedonia</option>
<option value="Madagascar"> Madagascar</option>
<option value="Malawi"> Malawi</option>
<option value="Malaysia"> Malaysia</option>
<option value="Maldives"> Maldives</option>
<option value="Mali"> Mali</option>
<option value="Malta"> Malta</option>
<option value="Marshall Islands"> Marshall Islands</option>
<option value="Martinique"> Martinique</option>
<option value="Mauritania"> Mauritania</option>
<option value="Mauritius"> Mauritius</option>
<option value="Mayotte"> Mayotte</option>
<option value="Mexico"> Mexico</option>
<option value="Micronesia"> Micronesia</option>
<option value="Moldova"> Moldova</option>
<option value="Monaco"> Monaco</option>
<option value="Mongolia"> Mongolia</option>
<option value="Montenegro"> Montenegro</option>
<option value="Montserrat"> Montserrat</option>
<option value="Morocco"> Morocco</option>
<option value="Mozambique"> Mozambique</option>
<option value="Myanmar"> Myanmar</option>
<option value="Namibia"> Namibia</option>
<option value="Nauru"> Nauru</option>
<option value="Nepal"> Nepal</option>
<option value="Netherlands"> Netherlands</option>
<option value="Netherlands Antilles"> Netherlands Antilles</option>
<option value="New Caledonia"> New Caledonia</option>
<option value="New Mexico"> New Mexico</option>
<option value="New Zealand"> New Zealand</option>
<option value="Nicaragua"> Nicaragua</option>
<option value="Niger"> Niger</option>
<option value="Nigeria"> Nigeria</option>
<option value="Niue"> Niue</option>
<option value="Norfolk Island"> Norfolk Island</option>
<option value="North Africa"> North Africa</option>
<option value="North Cyprus"> North Cyprus</option>
<option value="North Ethiopia"> North Ethiopia</option>
<option value="Northern Cyprus"> Northern Cyprus</option>
<option value="Northern Ethiopia"> Northern Ethiopia</option>
<option value="Northern Mariana Islands"> Northern Mariana Islands</option>
<option value="Norway"> Norway</option>
<option value="Oman"> Oman</option>
<option value="P.R. China"> P.R. China</option>
<option value="Pakistan"> Pakistan</option>
<option value="Palau"> Palau</option>
<option value="Palestine"> Palestine</option>
<option value="Palestinian Territory"> Palestinian Territory</option>
<option value="Panama"> Panama</option>
<option value="Papua New Guinea"> Papua New Guinea</option>
<option value="Paraguay"> Paraguay</option>
<option value="People&rsquo;s Republic of China"> People&rsquo;s Republic of China</option>
<option value="Peru"> Peru</option>
<option value="Philippines"> Philippines</option>
<option value="Pitcairn"> Pitcairn</option>
<option value="Poland"> Poland</option>
<option value="Portugal"> Portugal</option>
<option value="PR China"> PR China</option>
<option value="Puerto Rico"> Puerto Rico</option>
<option value="Qatar"> Qatar</option>
<option value="R&eacute;publique de C&ocirc;te d&rsquo;Ivoire"> R&eacute;publique de C&ocirc;te d&rsquo;Ivoire</option>
<option value="R.Macedonia"> R.Macedonia</option>
<option value="Republic of Armenia"> Republic of Armenia</option>
<option value="Republic of Belarus"> Republic of Belarus</option>
<option value="Republic of Benin"> Republic of Benin</option>
<option value="Republic of China"> Republic of China</option>
<option value="Republic of Indonesia"> Republic of Indonesia</option>
<option value="Republic of Iraq"> Republic of Iraq</option>
<option value="Republic of Ireland"> Republic of Ireland</option>
<option value="Republic of Kazakhstan"> Republic of Kazakhstan</option>
<option value="Republic of Korea"> Republic of Korea</option>
<option value="Republic of Kosovo"> Republic of Kosovo</option>
<option value="Republic of Macedonia"> Republic of Macedonia</option>
<option value="Republic of Mauritius"> Republic of Mauritius</option>
<option value="Republic of South Africa"> Republic of South Africa</option>
<option value="Republic of South Korea"> Republic of South Korea</option>
<option value="Republic of the Philippines"> Republic of the Philippines</option>
<option value="Republic of Tunisia"> Republic of Tunisia</option>
<option value="Republic of Uzbekistan"> Republic of Uzbekistan</option>
<option value="Republic of Yemen"> Republic of Yemen</option>
<option value="Republica Argentina"> Republica Argentina</option>
<option value="Reunion"> Reunion</option>
<option value="Romania"> Romania</option>
<option value="Russia"> Russia</option>
<option value="Russian Federation"> Russian Federation</option>
<option value="Rwanda"> Rwanda</option>
<option value="Saint Helena"> Saint Helena</option>
<option value="Saint Kitts and Nevis"> Saint Kitts and Nevis</option>
<option value="Saint Lucia"> Saint Lucia</option>
<option value="Saint Pierre and Miquelon"> Saint Pierre and Miquelon</option>
<option value="Saint Vincent and the Grenadines"> Saint Vincent and the Grenadines</option>
<option value="Samoa"> Samoa</option>
<option value="San Marino"> San Marino</option>
<option value="Sao Tome and Principe"> Sao Tome and Principe</option>
<option value="Saudi Arabia"> Saudi Arabia</option>
<option value="SCOTLAND"> SCOTLAND</option>
<option value="Senegal"> Senegal</option>
<option value="Seoul Korea"> Seoul Korea</option>
<option value="Serbia"> Serbia</option>
<option value="Serbia and Montenegro"> Serbia and Montenegro</option>
<option value="Seychelles"> Seychelles</option>
<option value="Sierra Leone"> Sierra Leone</option>
<option value="Singapore"> Singapore</option>
<option value="Slovak Republic"> Slovak Republic</option>
<option value="Slovakia"> Slovakia</option>
<option value="Slovenia"> Slovenia</option>
<option value="Solomon Islands"> Solomon Islands</option>
<option value="Somalia"> Somalia</option>
<option value="South Africa"> South Africa</option>
<option value="South Georgia"> South Georgia</option>
<option value="South Korea"> South Korea</option>
<option value="South Sudan"> South Sudan</option>
<option value="South-West Ethiopia"> South-West Ethiopia</option>
<option value="Southern Ethiopia"> Southern Ethiopia</option>
<option value="Spain"> Spain</option>
<option value="Sri Lanka"> Sri Lanka</option>
<option value="State of Kuwait"> State of Kuwait</option>
<option value="Sudan"> Sudan</option>
<option value="Sultanate of Oman"> Sultanate of Oman</option>
<option value="Suriname"> Suriname</option>
<option value="Svalbard and Jan Mayen"> Svalbard and Jan Mayen</option>
<option value="Swaziland"> Swaziland</option>
<option value="Sweden"> Sweden</option>
<option value="Switzerland"> Switzerland</option>
<option value="Syria"> Syria</option>
<option value="Syrian Arab Republic"> Syrian Arab Republic</option>
<option value="Taiwan"> Taiwan</option>
<option value="Taiwan"> Taiwan</option>
<option value="Taiwan, R.O.C"> Taiwan, R.O.C</option>
<option value="Tajikistan"> Tajikistan</option>
<option value="Tanzania"> Tanzania</option>
<option value="Tanzania"> Tanzania</option>
<option value="Thailand"> Thailand</option>
<option value="The Czech Republic"> The Czech Republic</option>
<option value="The Kingdom of Saudi Arabia"> The Kingdom of Saudi Arabia</option>
<option value="The Netherlands"> The Netherlands</option>
<option value="The People&rsquo;s Republic of China"> The People&rsquo;s Republic of China</option>
<option value="The Republic of Kenya"> The Republic of Kenya</option>
<option value="The Republic of Korea"> The Republic of Korea</option>
<option value="Timor-Leste"> Timor-Leste</option>
<option value="Togo"> Togo</option>
<option value="Tokelau"> Tokelau</option>
<option value="Tonga"> Tonga</option>
<option value="Trinidad and Tobago"> Trinidad and Tobago</option>
<option value="Tunisia"> Tunisia</option>
<option value="Tunisie"> Tunisie</option>
<option value="Turkey"> Turkey</option>
<option value="Turkish Republic of Northern Cyprus"> Turkish Republic of Northern Cyprus</option>
<option value="Turkmenistan"> Turkmenistan</option>
<option value="Turks and Caicos Islands"> Turks and Caicos Islands</option>
<option value="Tuvalu"> Tuvalu</option>
<option value="UAE"> UAE</option>
<option value="Uganda"> Uganda</option>
<option value="UK"> UK</option>
<option value="Ukraine"> Ukraine</option>
<option value="United Arab Emirates"> United Arab Emirates</option>
<option value="United Kingdom"> United Kingdom</option>
<option value="United Republic of Tanzania"> United Republic of Tanzania</option>
<option value="United States"> United States</option>
<option value="United States Minor Outlying Islands"> United States Minor Outlying Islands</option>
<option value="United States of America"> United States of America</option>
<option value="United States Virgin Islands"> United States Virgin Islands</option>
<option value="Unites Arab Emirates"> Unites Arab Emirates</option>
<option value="Uruguay"> Uruguay</option>
<option value="USA"> USA</option>
<option value="Uzbekistan"> Uzbekistan</option>
<option value="Vanuatu"> Vanuatu</option>
<option value="Vatican City"> Vatican City</option>
<option value="Venezuela"> Venezuela</option>
<option value="Vietnam"> Vietnam</option>
<option value="Virginia"> Virginia</option>
<option value="Wallis and Futuna"> Wallis and Futuna</option>
<option value="West Indies"> West Indies</option>
<option value="Western Australia"> Western Australia</option>
<option value="Western Sahara"> Western Sahara</option>
<option value="Yemen"> Yemen</option>
<option value="Zambia"> Zambia</option>
<option value="Zimbabwe"> Zimbabwe</option>
</select>
</div>
<div class="form-group">
<label for="lm_ri">Research Interest</label>
<input class="form-control" name="lm_ri" id="lm_ri" placeholder="Enter Your Research Here" type="text">
</div>
<div class="form-group">
<label for="lm_msg">Message</label>
<textarea class="form-control" rows="3" name="lm_msg" id="lm_msg" placeholder="Enter Message "></textarea>
</div>
<div class="form-group">
<label for="usr">Anti Spam Code:</label>
<input id="captcha1" name="captcha1" type="text" required class="form-control" style="width:100px; font-weight:bold; color:#003399; text-align:center; font-size:14px;" maxlength="6">
<img src="../captcha_code_file1.php?rand=1811217386" id='captchaimg1' align="absmiddle" alt="captcha"> &nbsp;&nbsp;<a href='javascript: refreshCaptcha1();'><img src="https://www.omicsonline.org/images/refresh.jpg" width="24" height="24" align="absmiddle" border="0" alt="Reload" title="Reload"></a>&nbsp;&nbsp;Can't read the image? <a href='javascript: refreshCaptcha1();' title="Click here">click here</a> to refresh
</p>
</div>
</div>
</div>
</div>
</div>
<div class="modal-footer">
<button type="button" class="btn btn-secondary" data-dismiss="modal">Close</button>

<input type="submit" class="btn btn-primary" name="submitnew" value="Submit" />
</div>
</div>
</form>
</div>
</div>
<script type="b97a614b378fa63bf320b38b-text/javascript">
function refreshCaptcha1() {
var img = document.images[ 'captchaimg1' ];
img.src = img.src.substring(0, img.src.lastIndexOf("?")) + "?rand=" + Math.random() * 1000;
}
</script>
<script type="b97a614b378fa63bf320b38b-">
$(document).ready(function () {
$("#leavemessage_form").submit(function () {

$(".error").hide();
var hasError = false;
//var emailReg = /^([\w-\.]+@([\w-]+\.)+[\w-]{2,4})?$/;
var lm_name=$("#lm_name").val();
var lm_email=$("#lm_email").val();
var lm_phone=$("#lm_phone").val();
var lm_country=$("#lm_country").val();
var lm_ri=$("#lm_ri").val();
var lm_msg=$("#lm_msg").val();
var captcha1=$("#captcha1").val();
var journal=$("#journal").val();
var art_id=$("#art_id").val();

$("#msgbox2").html('<img src="https://www.omicsonline.org/images/wait.gif" alt="Wait" width="128" height="15"/><br> <font color="green">Loading Please wait....</font>').fadeIn(1000);
//check the username exists or not from ajax
$.post("https://www.omicsonline.org/leave-message-postings.php", {
journal: journal,
art_id: art_id,
lm_name: lm_name,
lm_email: lm_email,
lm_phone: lm_phone,
lm_country: lm_country,
lm_ri: lm_ri,
lm_msg: lm_msg,
captcha1: captcha1,
rand: Math.random()
}, function (data) {
if (data == 'yes') //if correct login detail
{
$("#msgbox2").fadeTo(200, 0.8, function () //start fading the messagebox
	{
		$(this).html('<font color="green">Thank you for submitting your message. Our team will get back soon.</font>').addClass('messageboxok').fadeTo(3000, 1,
			//add message and change the class of the box and start fading
			//$(this).html('Logging in ,Please wait...').addClass('messageboxok').fadeTo(900,1,
			function () {
				//redirect to secure page
				$(this).html('<font color="green">Thank you for submitting your message. Our team will get back soon.</font>').addClass('messageboxerror').fadeTo(900, 1);
								document.location = 'https://www.omicsonline.org/open-access/intense-therapeutic-ultrasound-for-chronic-lateral-epicondylitis-pain-reduction-2161-0673-1000202-100794.html';
			}
		);

	});
} else {
$("#msgbox2").fadeTo(200, 0.1, function () //start fading the messagebox
	{
		//add message and change the class of the box and start fading
		$(this).html('<font color="red">The Validation code does not match..!</font>').addClass('messageboxerror').fadeTo(900, 1);
	});
}

});
return false; //not to post the  form physically
});
});
</script>
<script type="b97a614b378fa63bf320b38b-">
		$(document).on('click', 'a[href^="#"]', function (event) {
			event.preventDefault();

			$('html, body').animate({
				scrollTop: $($.attr(this, 'href')).offset().top-10
			}, 500);
		});
	</script>
<script src="https://ajax.cloudflare.com/cdn-cgi/scripts/4f936b58/cloudflare-static/rocket-loader.min.js" data-cf-nonce="b97a614b378fa63bf320b38b-" defer=""></script></body>
</html>